Gene therapy - promises, problems and prospects View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1997-09

AUTHORS

Inder M. Verma, Nikunj Somia

ABSTRACT

N/A

PAGES

239-242

References to SciGraph publications

Journal

TITLE

Nature

ISSUE

6648

VOLUME

389

Related Patents

  • Polynucleotides Encoding Antigenic Hiv Type C Polypeptides, Polypeptides And Uses Thereof
  • Methods For The Early Diagnosis Of Ovarian Cancer
  • Il-17 Receptor A Antigen Binding Proteins
  • Integration-Site Directed Vector Systems
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Method For Detecting Cancer Cells And Monitoring Cancer Therapy
  • Improved Genetic Elements Providing High Levels Of Expression
  • Promoter To Il-18bp, Its Preparation And Use
  • Therapeutic Antiangiogenic Endostatin Compositions
  • Vascular Endothelial Growth Factor 2
  • Infectious Recombinant Paramyxovirus From Antigenomic Cdna
  • Treatment Of Parkinson's Disease And Related Disorders Using Postpartum Derived Cells
  • Viral Vector System, A Composition Comprising The Viral Vector System And Its Use
  • Methods Of Administering/Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment
  • Ultrasound Radiating Members For Catheter
  • Methods And Compositions For Detection Of Microorganisms And Cells And Treatment Of Diseases And Disorders
  • Methods Of Treating Psoriasis Using Il-17 Receptor A Antibodies
  • Methods And Compositions For Regeneration Of Aged Skeletal Muscle Tissues
  • Modified Cdna Of Rat Bcl-X Gene And Modified Protein
  • Methods For Treating Cancer Using Cytokine-Expressing Polynucleotides
  • Transgenic Animals And Cell Lines For Screening Drugs Effective For The Treatment Or Prevention Of Alzheimer's Disease
  • Treatment Of Diseases By Site Specific Instillation Of Cells Or Site Specific Transformation Of Cells And Kits Therefor
  • Transgenic Animals And Cell Lines For Screening Drugs Effective For The Treatment Or Prevention Of Alzheimer's Disease
  • Nima Interacting Proteins
  • Cannie Il-5 Nucleic Acid Molecules
  • Methods And Compositions For Treating Prostate Cancer Using Dna Vaccines
  • Human Tyrosine Hydroxylase Promoter And Uses Thereof
  • Spatial And Temporal Control Of Gene Expression Using A Heat Shock Protein Promoter In Combination With Local Heat
  • Gene Repair Involving In Vivo Excision Of Targeting Dna
  • Lentiviral Ltr-Deleted Vector
  • Compositions And Methods For Inducing Gene Expression
  • Compositions And Methods For The Therapeutic Use Of An Atonal-Associated Sequence For Deafness, Osteoarthritis, And Abnormal Cell Proliferation
  • Methods For Transfecting T Cells
  • Method To Improve Translation Of Polypeptides By Using Untranslated Regions From Heat-Shock Proteins
  • Method Of Enhancing Relaxation Of Penile Smooth Muscle By Introduction Of Dna Encoding Maxi-K Potassium Channel Protein
  • Ags Proteins And Nucleic Acid Molecules And Uses Therefor
  • Use Of Locally Applied Dna Fragments
  • Homeodomain Protein Code Specifying Progenitor Cell Identify And Neuronal Fate In The Ventral Neural Tube
  • Suppressor Trna System
  • Inhibition Of Vascular Smooth Muscle Cell Proliferation
  • Vanilrep1 Polynucleotides And Vanilrep1 Polypeptides
  • Combinations And Methods For Promoting In Vivo Liver Cell Proliferation And Enhancing In Vivo Liver-Directed Gene Transduction
  • Intramuscular Delivery Of Recombinant Aav
  • Dna-Based Transposon System For The Introduction Of Nucleic Acid Into Dna Of A Cell
  • Dry Powder Compositions
  • Adenovirus Vectors Specific For Cells Expressing Androgen Receptor And Methods Of Use Thereof
  • Compositions And Methods For Inducing Gene Expression
  • Cationic Liposomal Delivery System And Therapeutic Use Thereof
  • Methods Of Improving Homologous Recombination
  • Virus-Like Particles Useful As A Vector For Delivering Nucleic Acid
  • Non-Defective Epstein-Barr Viral Vector
  • Method For Nucleic Acid Transfection Of Cells
  • Method For Inhibiting Herpes Infection
  • Human Intestinal Npt2b
  • Methods Of Modulating Of Angiogenesis
  • Mutated Herpes Simplex Virus Type 1 Thymidine Kinases And Uses Thereof
  • Immunovectors For The Intracellular And Intranuclear Transport
  • Expression Of Hiv Polypeptides And Production Of Virus-Like Particles
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Knockout Mouse For The Tumor Suppressor Gene Anx7
  • Use Of A Cytokine-Producing Lactococcus Strain To Treat Colitis
  • Artificial Salivary Gland
  • Method Of Making Microencapsulated Dna For Vaccination And Gene Therapy
  • Adenoviral Vector With A Deletion In The E1a Coding Region Expressing A Hetorologous Protein
  • Strategy For Suppressing The Expression Of An Endogeneous Gene By Using Compounds That Are Able To Bind To The Non-Coding Regions Of The Gene To Be Suppressed
  • Tissue Specific Adenoviral Vectors
  • Use Of Lecithin-Cholesterol Acyltransferase (Lcat) To Reduce Accumulation Of Cholesterol
  • Bioconjugates And Delivery Of Bioactive Agents
  • Targeted Integration Into Chromosomes Using Retroviral Vectors
  • Immunologic Enhancement With Intermittent Interleukin-2 Therapy
  • Chimeric Poxvirus Comprising Sequences Of A Retroviral Vector Component
  • Natural Or Synthetic Retroelement Sequence Enabling Nucleotide Sequence Insertion Into A Eukaryotic Cell
  • Endothelial Specific Expression Regulated By Epcr Control Elements
  • Hiv-Mscv Hybrid Viral Vector For Gene Transfer
  • Compositions And Methods For Activating Genes Of Interest
  • Peptide-Lipid Conjugates, Liposomes And Lipsomal Drug Delivery
  • Artemin, A Novel Neurotrophic Factor
  • Transfection, Storage And Transfer Of Male Germ Cells For Generation Of Transgenic Species And Genetic Therapies
  • Suppression Of Malignancy Utilizing Ribonucleotide Reductase R1
  • Adeno-Associated Virus And Adenovirus Chimeric Recombinant Viruses Useful For The Integration Of Foreign Genetic Information Into The Chromosomal Dna Of Target Cells
  • Antibody Specific For A Protein Tyrosine Phosphatase That Localizes To Focal Adhesions
  • Hemoglobin-Haptoglobin Complexes
  • Gene Delivery Vectors Provided With A Tissue Tropism For Smooth Muscle Cells, And/Or Endothelial Cells
  • Tissue Factor For Influencing Blood Vessel Formation
  • Targeting Of Molecules To Large Vessel Endothelium Using Epcr
  • Vectors For Delivering Viral And Oncogenic Inhibitors
  • Methods Related To Immunostimulatory Nucleic Acid-Induced Interferon
  • Murine Monoclonal Anti-Idiotype Antibody 11d10 And Methods Of Use Thereof
  • Retroviral Vector For The Transfer And Expression Of Genes For Therapeutic Purposes In Eukaryotic Cells
  • In-Situ Gel Formation Of Pectin
  • Encapsulated Cells Producing Viral Particles
  • Non-Identical Genes And Their Application In Improved Molecular Adjuvants
  • Hkis Compositions And Methods Of Use
  • Gene Therapy Method For Reducing Risk Of Atherosclerosis
  • Gene Therapy Using Tgf-Β
  • Sphingosine Kinases
  • Retroviral Vectors Comprising A Functional Splice Donor Site And A Functional Splice Acceptor Site
  • Methods For Generating Genetically Altered Antibody Producing Cell Lines With Improved Antibody Characteristics
  • Prevention And Treatment Of Amyloidogenic Disease
  • Hepatitis C Virus Vaccine
  • Coding Sequences Of The Human Brca1 Gene
  • Gene Delivery By Microneedle Injection
  • Method Of Gene Delivery Using Wildtype Adeno Associated Viral (Aav) Vectors With Insertions
  • Gene Therapies For Enhancing Cardiac Function
  • Vectors
  • Prevention And Treatment Of Amyloidgenic Disease
  • Expression Of Hiv Polypeptides And Production Of Virus-Like Particles
  • Vector
  • Method For In Vivo Regulation Of Cardiac Muscle Contractility
  • Imaging, Diagnosis And Treatment Of Disease
  • Use Of Nf-Κb Inhibition In Combination Therapy For Cancer
  • Biodegradable Cationic Polymers
  • Targeted Vectors For Cancer Immunotherapy
  • Methods For Treating Diabetes Using Fibroblast Growth Factor-Like Polypeptides
  • Use Of Nf-Κb Inhibition In Combination Therapy For Cancer
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Neutralizing Determinants Of Il-17 Receptor A And Antibodies That Bind Thereto
  • Method And Apparatus To Modulate Cellular Regeneration Post Myocardial Infarct
  • Duplexed Parvovirus Vectors
  • Compositions For Importing Biologically Active Molecules Into Cells
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Regeneration And Repair Of Neural Tissue Using Postpartum-Derived Cells
  • Mrna Ratios In Urinary Sediments And/Or Urine As A Prognostic And/Or Theranostic Marker For Prostate Cancer
  • Biodegradable Cationic Polymers
  • Bivalent Swine Influenza Virus Vaccine
  • High Titer Recombinant Influenza Viruses For Vaccines
  • High Titer Recombinant Influenza Viruses With Enhanced Replication In Mdck Or Vero Cells Or Eggs
  • Control Of Gene Expression
  • Method Of Treating Psoriasis Using An Il-17 Receptor Antibody Formulation
  • Methods For Treating Obesity Using Fibroblast Growth Factor-Like Polypeptides
  • Regulated Apoptosis
  • Multi-Antigenic Alphavirus Replicon Particles And Methods
  • Methods And Compositions For Treatment Of Interferon-Resistant Tumors
  • Targeted Retrograde Gene Delivery To Motor Neurons
  • Fibroblast Growth Factor-Like Polypeptides And Variants Thereof
  • Method And Circuit Arrangement For Treating Biomaterial
  • Attenuated Negative Strand Viruses With Altered Interferon Antagonist Activity For Use As Vaccines And Pharmaceuticals
  • Antisense Modulation Of Ptp1b Expression
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Avian Adenoassociated Virus And Uses Thereof
  • Method Of Targeted Gene Delivery Using Viral Vectors
  • Rna Interference Mediating Small Rna Molecules
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Methods Of Treating Psoriasis Using Il-17 Receptor A Antibodies
  • Treatment Of Tumors With Genetically Engineered Herpes Virus
  • Fibroblast Growth Factor-Like Polypeptides
  • Engineered Nucleic Acids Encoding A Modified Erythropoietin And Their Expression
  • Hydrophobic Biomolecular Structure
  • Methods And Compositions For Treating Conditions Involving Abnormal Angiogenesis
  • Ultrasonic Catheter Power Control
  • Transfection Agents
  • Selective Toxin Expression In Angiogenic Endothelial Cells
  • Genetically Engineered Swine Influenza Virus And Uses Thereof
  • Adenovirus Vectors Specific For Cells Expressing Androgen Receptor And Methods Of Use Thereof
  • Ubiqutin Proteases
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Composition And Method For The Diagnosis And Treatment Of Diseases Associated With Neurite Degeneration
  • Multispecific Deimmunized Cd3-Binders
  • Methods Of Inducing Regulated Pancreatic Hormone Production In Non-Pancreatic Islet Tissues
  • Methods For Therapy Of Neurodegenerative Disease Of The Brain
  • Treatment Of Peripheral Vascular Disease Using Umbilical Cord Tissue-Derived Cells
  • Composition And Methods For The Therapeutic Use Of An Atonal-Associated Sequence For Deafness, Osteoarthritis And Abnormal Cell Proliferation
  • Compositions And Methods For Polynucleotide Delivery
  • Application Of Mrna For Use As A Therapeutic Agent For Tumorous Diseases
  • Herpes Simplex Virus Vaccines
  • Chimeric Tumor Suppressor Gene And Protein
  • Polynucleotide
  • Treatment With A Pharmaceutical Composition Comprising Manf2 Necleic Acid
  • Postpartum Cells Derived From Umbilical Cord Tissue, And Methods Of Making And Using The Same
  • Adenoviral Targeting And Manipulation Of Immune System Response Using Targeting Peptides
  • Compositions And Methods For Elimination Of Unwanted Cells
  • Compositions And Methods For Elimination Of Unwanted Cells
  • Method To Enhance Treatment Of Cystic Tumors
  • Methods And Products For Delivering Nucleic Acids
  • Method For Treatment Of Depression
  • Complex Immuno-Gene Medical Composition For Inhibiting Tumor Cells
  • Method Of Administering Porcine B-Domainless Fviii
  • Attenuated Negative Strand Viruses With Altered Interferon Antagonist Activity For Use As Vaccines And Pharmaceuticals
  • Screening Methods Using G-Protein Coupled Receptors And Related Compositions
  • Polypeptide Derivatives Of Parathyroid Hormone (Pth)
  • Compositions And Methods For Therapeutic Use
  • Compositions And Methods For Enhancing Delivery Of Therapeutic Agents To Cells
  • Nucleic Acid Compositions For Stimulating Immune Responses
  • Adamts13 Genes And Proteins And Variants And Therapeutic Compositions And Methods Utilizing The Same
  • Antibodies
  • Method For Importing Biologically Active Molecules Into Cells
  • Nucleic Acid Constructs Cells Transformed Therewith And Methods Utilizing Same For Inducing Liver Regeneration And Alleviation Of Portal Hypertension
  • Heat Shock Protein-Based Vaccines And Immunotherapies
  • Method For Treating Kidney Disorders
  • Lymphoma Associated Molecules And Uses Therefor
  • Secreted Epithelial Colon Stromal-1 Molecules And Uses Thereof
  • Treatment Of Amyloidogenic Diseases
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Method For Rational Mutagenesis Of Α/Βt-Cell Receptors And Correspondingly Mutated Mdm2-Protein Specific Α/Βt-Cell Receptors
  • Rsv Specific Binding Molecule
  • Modified Polynucleotides Encoding Granulysin
  • Hiv-1 South African Subtype C Env Proteins
  • Methods Of Treating Parkinson's Disease Using Viral Vectors
  • Modified Polynucleotides For Treating Galactosylceramidase Protein Deficiency
  • Synthetic Genes And Genetic Constructs
  • Spatial And Temporal Control Of Gene Expression Using A Heat Shock Protein Promoter In Combination With Local Heat
  • Adenovirus Vectors Specific For Cells Expressing Androgen Receptor And Methods Of Use Thereof
  • Ubiqutin Proteases
  • Modified Cdna Of Rat Bcl-X Gene And Modified Protein
  • Methods For Treating Cancer Using Cytokine-Expressing Polynucleotides
  • Hydrophobic Biomolecular Structure
  • Distinguishing Pca3 Messenger Rna Species In Benign And Malignant Prostate Tissues
  • Methods Of Gene Therapy Using Nucleic Acid Sequences For Atp-Binding Cassette Transporter
  • Immunostimulatory Nucleic Acid Molecules
  • Methods For Treating Restenosis
  • Antagonists Of Tweak And Of Tweak Receptor And Their Use To Treat Immunological Disorders
  • Compositions And Their Uses Directed To Acetyl-Coa Carboxylases
  • Methods And Compositions For Silencing Genes Without Inducing Toxicity
  • Methods For The Propagation Of Modified Influenza Viruses In Embryonated Eggs
  • Multispecific Deimmunized Cd3-Binders
  • Composition And Method For The Diagnosis And Treatment Of Diseases Associated With Neurite Degeneration
  • Postpartum Cells Derived From Umbilical Cord Tissue, And Methods Of Making And Using The Same
  • Method For Rational Mutagenesis Of Α/Βt-Cell Receptors And Correspondingly Mutated Mdm2-Protein Specific Α/Βt-Cell Receptors
  • Chimeric Vectors
  • Method Of Inhibiting Angiogenesis Or Invasion Or Formation Of Metastases
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Promoters Exhibiting Endothelial Cell Specificity And Methods Of Using Same
  • Vesicular Stomatitis Viruses
  • Compositions And Methods For Regulating Angiogenesis
  • Application Of Mrna For Use As A Therapeutic Agent For Tumorous Diseases
  • Method To Enhance Treatment Of Cystic Tumors
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Treatment With A Pharmaceutical Composition Comprising Manf2 Necleic Acid
  • Compositions And Methods For Elimination Of Unwanted Cells
  • Compositions And Methods For Elimination Of Unwanted Cells
  • Methods And Products For Delivering Nucleic Acids
  • Modified Polynucleotides For Treating Galactosylceramidase Protein Deficiency
  • Synthetic Genes And Genetic Constructs
  • Composition And Methods For The Therapeutic Use Of An Atonal-Associated Sequence For Deafness, Osteoarthritis And Abnormal Cell Proliferation
  • Compositions And Methods For Polynucleotide Delivery
  • Selective Target Cell Activation By Expression Of A G Protein-Coupled Receptor Activated Superiorly By Synthetic Ligand
  • Compounds And Methods For Therapy And Diagnosis Of Lung Cancer
  • Compositions And Methods For The Treatment Of Cancer Using Recombinant Viral Vector Delivery Systems
  • Method Of Inducing Angiogenesis
  • Methods For Therapy Of Neurodegenerative Disease Of The Brain
  • Method For Treatment Of Depression
  • Adenoviral Targeting And Manipulation Of Immune System Response Using Targeting Peptides
  • Methods Of Inducing Regulated Pancreatic Hormone Production In Non-Pancreatic Islet Tissues
  • Postpartum-Derived Cells For Use In Treatment Of Disease Of The Heart And Circulatory System
  • Methods And Means For Obtaining Modified Phenotypes
  • Postpartum Cells Derived From Umbilical Cord Tissue, And Methods Of Making And Using The Same
  • Herpes Simplex Virus Vaccines
  • Adenoviral Vector Comprising Herpes Simplex Virus Type 1 Thymidine Kinase And A Transgene For Increasing The Expression Of The Transgene
  • Adamts13 Genes And Proteins And Variants, And Therapeutic Compositions And Methods Of Utilizing The Same
  • Targeted Gene Modification By Parvoviral Vectors
  • Chimeric Tumor Suppressor Gene And Protein
  • Polynucleotide
  • Methods Of Using Il-17 Receptor A Antibodies
  • Tumour Cell Lines And Uses Thereof
  • Ultrathin Multilayered Films For Controlled Release Of Anionic Reagents
  • Polypeptide Derivatives Of Parathyroid Hormone (Pth)
  • Method Of Administering Porcine B-Domainless Fviii
  • Methods Of Treating Parkinson's Disease Using Viral Vectors
  • Rsv Specific Binding Molecule
  • Modified Polynucleotides Encoding Granulysin
  • Hiv-1 South African Subtype C Env Proteins
  • Complex Immuno-Gene Medical Composition For Inhibiting Tumor Cells
  • Modified Factor Viii
  • Method For Regulating Genes With Electromagnetic Response Elements
  • Controlled Release Of Bioactive Substances
  • Method For Generating Genetically Altered Antigens
  • Induction Of Programmed Cell Death By N5 Gene
  • Attenuated Negative Strand Viruses With Altered Interferon Antagonist Activity For Use As Vaccines And Pharmaceuticals
  • Screening Methods Using G-Protein Coupled Receptors And Related Compositions
  • Charge-Dynamic Polymers And Delivery Of Anionic Compounds
  • Tumour Cell Lines And Uses Thereof
  • Human Fgf Receptor And Β-Klotho Binding Proteins
  • Nucleic Acid Molecules Encoding Fibroblast Growth Factor-Like Polypeptides
  • Humanized Antibodies That Recognize Β-Amyloid Peptide
  • Use Nf-Κb Inhibition In Combination Therapy For Cancer
  • Selectivity Replicating Viral Vector
  • Nucleic Acids Encoding The Human Alex1 Protein
  • Methods Of Increasing Lean Tissue Mass Using Ob Protein Compositions
  • Vectors And Recombinant Host Cells Comprising Nucleic Acid Molecules Encoding Fibroblast Growth Factor-Like Polypeptides
  • Pca3 Messenger Rna Species In Benign And Malignant Prostate Tissues
  • Methods Of Activating Ret Receptor Tyrosine Kinase Using Neurotrophic Factors
  • Stable Lipid-Comprising Drug Delivery Complexes And Methods For Their Production
  • Ancestral And Cot Viral Sequences, Proteins And Immunogenic Compositions
  • Cell Lines
  • Adeno-Associated Virus Materials And Methods
  • Antisense Modulation Of Ptp1b Expression
  • Modified Polynucleotides Encoding Apoptosis Inducing Factor 1
  • Refolding Transforming Growth Factor Beta Family Proteins
  • Rna Interference Mediating Small Rna Molecules
  • Ultrasonic Catheter Power Control
  • Antisense Modulation Of Ptp1b Expression
  • Prevention And Treatment Of Amyloidogenic Disease
  • Method Of Delivery Of Nucleic Acids To A Developing Embryo
  • Modified Polynucleotides For The Production Of Nuclear Proteins
  • Parathyroid Hormone Analogs And Uses Thereof
  • Human Antigen Binding Proteins That Bind Β-Klotho, Fgf Receptors And Complexes Thereof
  • Modified Polynucleotides Encoding Cited4
  • Polynucleotides For Reducing Respiratory Syncytial Virus Gene Expression
  • Hepatitis Therapeutics
  • Lipid Complexes For Transferring At Least A Therapeutically Active Substance, In Particular A Polynucleotide Into A Target Cell And Use In Gene Therapy
  • Identifying Modulators Of Fibroblast Growth Factor-Like Polypeptides
  • Infection And Treatment Of Neoplasms With Vesicular Stomatitis Virus
  • Thrombopoietic Compounds
  • Correction Of Alpha-1-Antitrypsin Genetic Defects Using Spliceosome Mediated Rna Trans Splicing
  • Epicardial Patch Including Isolated Extracellular Matrix With Pacing Electrodes
  • Vectorization System Comprising Nanoparticles Of Homogenous Size Of At Least One Polymer And At Least One Positively Charged Polysaccharide And Method For The Preparation Thereof
  • Modified Vaccinia Virus Strains For Use In Diagnostic And Therapeutic Methods
  • Peptide-Enhanced Transfections
  • Promoters Exhibiting Endothelial Cell Specificity And Methods Of Using Same For Regulation Of Angiogenesis
  • Vascular Endothelial Growth Factor 2
  • Non-Ionically Bound Constructs, And Compositions And Kits Comprising Domains
  • Promoters Exhibiting Endothelial Cell Specificity And Methods Of Using Same
  • Double-Stranded Oligonucleotides
  • Humanized Aβ Antibodies For Use In Improving Cognition
  • Light Emitting Microorganisms And Cells For Diagnosis And Therapy Of Tumors
  • Property Effecting And/Or Property Exhibiting Compositions For Therapeutic And Diagnostic Uses
  • Replication-Competent Anti-Cancer Vectors
  • Fgf21 Mutants Multimers And Uses Thereof
  • Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
  • Polymer Conjugates Of Mutated Neublastin
  • Chimeric Polypeptides And Uses Thereof
  • Light Emitting Microorganisms And Cells For Diagnosis And Therapy Of Diseases Associated With Wounded Or Inflamed Tissue
  • Stress-Responsive Induction Of A Therapeutic Agent And Methods Of Use
  • Tetracycline Repressor Regulated Oncolytic Viruses
  • Circuit Arrangement For Injecting Nucleic Acids And Other Biologically Active Molecules Into The Nucleus Of Higher Eucaryotic Cells Using Electrical Current
  • Method Of Detection Of Nucleic Acids With A Specific Sequence Composition
  • Cdna Corresponding To The Antigenome Of Nonsegmented Negative Strand Rna Viruses, And Process For The Production Of Such Viruses Encoding Additional Antigenically Active Proteins
  • Her2 Dna Vaccine As Adjunct Treatment For Cancers In Companion Animals
  • Selectivity Replicating Viral Vector
  • Nucleic Acids Encoding The Human Alex1 Protein
  • Cell Lines
  • Pca3 Messenger Rna Species In Benign And Malignant Prostate Tissues
  • Methods Of Activating Ret Receptor Tyrosine Kinase Using Neurotrophic Factors
  • Stable Lipid-Comprising Drug Delivery Complexes And Methods For Their Production
  • Ancestral And Cot Viral Sequences, Proteins And Immunogenic Compositions
  • Rna Sequence-Specific Mediators Of Rna Interference
  • Tumor Suppressor Killin
  • Modified Vaccinia Virus Strains For Use In Diagnostic And Therapeutic Methods
  • Rna Sequence-Specific Mediators Of Rna Interference
  • Tetracycline-Regulated Gene Expression In Hsv-1 Vectors
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Tc-83-Derived Alphavirus Vectors, Particles And Methods
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Herpes Simplex Virus Vaccines
  • Mutations That Confer Genetic Stability To Additional Genes In Influenza Viruses
  • Method To Detect Prostate Cancer In A Sample
  • Hbv Epitope Reactive Exogenous T Cell Receptor (Tcr) And Uses Thereof
  • Soft Tissue Repair And Regeneration Using Postpartum-Derived Cells And Cell Products
  • Hutc As Therapy For Alzheimer's Disease
  • Methods And Compositions For Promoting Survival And Proliferation Of Endothelial Cells And Stimulating Angiogenesis
  • Modified Vaccinia Virus Strains For Use In Diagnostic And Therapeutic Methods
  • Compositions And Methods For Treating Pancreatic Cancer
  • Oligonucleotide Compositions With Enhanced Efficiency
  • Osf2/Cbfa1 Nucleic Acids And Methods Of Use Therefor
  • Retroviral Vectors
  • Modified Polynucleotides Encoding Cited4
  • Modified Polynucleotides For The Production Of Nuclear Proteins
  • Fk506-Based Regulation Of Biological Events
  • Targeted Retrograde Gene Delivery To Motor Neurons
  • Parathyroid Hormone Analogs And Uses Thereof
  • Modified Polynucleotides Encoding Septin-4
  • Human Antigen Binding Proteins That Bind Β-Klotho, Fgf Receptors And Complexes Thereof
  • Polynucleotides For Reducing Respiratory Syncytial Virus Gene Expression
  • Methods Of Treating Metabolic Disease
  • Compositions And Methods For Angiogenic Therapy Utilizing Genes Encoding Ets-1
  • Methods For Producing Micrornas
  • Treatment Of Neurological Injury By Administration Of Human Umbilical Cord Tissue-Derived Cells
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Oligonucleotide Compositions With Enhanced Efficiency
  • Materials And Methods For Producing Improved Lentiviral Vector Particles
  • Interleukin-9 And Interleukin-4 Chimeric Antagonist Muteins And Methods Of Using Same
  • Genetic Inhibition By Double-Stranded Rna
  • Methods Of Treating Parkinson's Disease Using Viral Vectors
  • Method Of Inhibiting The Generation Of Active Thrombin On The Surface Of A Cell Within An Atherosclerotic Plaque
  • Methods Of Treating Various Cancers Using Melanoma Differentiation Associated Protein-7
  • Implantable Drug Delivery Device And Use Thereof
  • Modified Factor Viii
  • Genetic Inhibition By Double-Stranded Rna
  • Use Of Vegf And Homologues To Treat Neuron Disorders
  • Photochemical Internalization For Virus-Mediated Molecule Delivery Into The Cyosol
  • Inhibition Of Lipoprotein Secretion
  • Therapeutic Agent For Infections, And Treatment Method Using Same
  • Humanized Antibodies That Recognize Beta Amyloid Peptide
  • Uses Of Fgf21 Polypeptides Comprising Two Or More Mutations
  • Rna Interference Mediating Small Rna Molecules
  • Duplexed Parvovirus Vectors
  • Repair And Regeneration Of Ocular Tissue Using Postpartum-Derived Cells
  • Regeneration And Repair Of Neural Tissue Using Postpartum-Derived Cells
  • Rna Interference Mediating Small Rna Molecules
  • Antibody Fragment-Targeted Immunoliposomes For Systemic Gene Delivery
  • Vascular Endothelial Growth Factor 2
  • Prostate Cancer Prognostic Compositions And Kits
  • Receptor That Binds Il-17
  • Bioactive Peptides And Peptide Derivatives Of Parathyroid Hormone (Pth) And Parathyroid Hormone-Related Peptide (Pthrp)
  • Hepatitis Therapeutics
  • Lipid Complexes For Transferring At Least A Therapeutically Active Substance, In Particular A Polynucleotide Into A Target Cell And Use In Gene Therapy
  • Materials And Methods For Delivery And Expression Of Heterologous Dna In Vertebrate Cells
  • Method For Modulating Expression Of Exogenous Genes In Mammalian Systems, And Products Related Thereto
  • Nucleic Acid Delivery
  • Compositions And Methods For The Therapy And Diagnosis Of Colon Cancer
  • Mammalian Cell Lines Expressing Bovine Adenovirus Functions
  • Dna Molecules Encoding Single Strand Gap Response Proteins Involved In Activation Of A Dna Repair/Cell Cycle Checkpoint Pathway
  • Human Narcolepsy Gene
  • Recombinant P53 Adenovirus Compositions
  • Neurotransmitter Transporter Sc6
  • Growth Hormone Releasing Hormone Expression System And Methods Of Use, Including Use In Animals
  • Prevention Of Cell Migration Initiation With Cmv Us28 Receptor Antagonists
  • Oxygen Sensing And Hypoxic Selection For Tumors
  • Compositions And Methods For Polynucleotide Delivery
  • Retinoblastoma Protein-Interacting Zinc Finger Proteins
  • Compositions And Methods For Delivery Of Genetic Material
  • Use Of A Vector Expressing Dna Polymerase Β As Medicine
  • Gene Therapy For Pulmonary Edema Using Adenovirus Vectors Encoding Na,K-Atpase
  • Gene Treatment To Enhance Feed Efficiency And Growth Rate Of Livestock
  • Scleroprotein Of An Adeno-Associated Virus With Modified Chromatographic Properties, The Production Thereof And Use Of The Same
  • Adenovirus Vector Containing A Heterologous Peptide Epitope In The Hi Loop Of The Fiber Knob
  • Rna Interference Mediating Small Rna Molecules
  • Suppressor Of Cytokine Signaling (Socs)-3 Promoter And Methods For Its Use In Genetic Therapy In Humans
  • Complex Of Biotinylated Viral Vector And Ligand For Targeted Gene Delivery
  • Immunomodulatory Polynucleotides In Treatment Of An Infection By An Intracellular Pathogen
  • Super-Active Porcine Growth Hormone Releasing Hormone Analog
  • Preventing Airway Mucus Production By Administration Of Egf-R Antagonists
  • Destruction Of The Epithelium Of An Exocrine Gland In The Prophylactic And Therapeutic Treatment Of Cancer
  • Vaccines For Chlamydia Psittaci Infections
  • Helper Virus-Free Herpesvirus Vector Packaging System
  • In Vivo Production And Delivery Of Erythropoietin Or Insulinotropin For Gene Therapy
  • Dna And Protein For The Diagnosis And Treatment Of Alzheimer's Disease
  • Method Of Screening Compounds For Controlling Capacitative Calcium Ion Entry Into Mammalian Cells
  • Wnt-3 Polynucleotides
  • Somatic Gene Therapy To Suppress Secondary Cataract Formation Following Eye Surgery
  • Recombinant Adenovirus And Adeno-Associated Virus, Cell Lines And Methods Of Production And Use Thereof
  • Method Of Transferring A Dna Sequence To A Cell In Vitro
  • Method Of Expressing An Exogenous Nucleic Acid
  • Therapeutic And Drug Screening Methods For The Treatment And Prevention Of Neuronal Disease
  • Method Of Controlling L-Dopa Production And Of Treating Dopamine Deficiency
  • Targeted Chromosomal Genomic Alterations With Modified Single Stranded Oligonucleotides
  • Plasmid Vector Comprising A Retroviral Integrase Gene And An Integrase Recognition Region
  • Ob Fusion Protein Compositions And Methods
  • Alternate Site Gene Therapy
  • Treating Anemia In Subjects By Administration Of Plasmids Encoding Growth Hormone Releasing Hormone
  • 2786, A Novel Human Aminopeptidase
  • Compositions And Methods For Elimination Of Unwanted Cells
  • Mouse Telomerase Reverse Transcriptase
  • Human Abc1 Promoter And Assays Based Thereon
  • Gene Expression With Covalently Modified Polynucleotides
  • Targeted Vectors
  • Active Immunization For Treatment Of Alzheimer's Disease
  • Viral Expression Vectors Comprising A Ribosomal Promoter Sequence
  • Neurotrophic Factors
  • Efficient Ex Vivo Expansion Of Cd4+ And Cd8− T-Cells From Hiv Infected Subjects
  • Recombinant, Active Caspases And Uses Thereof
  • Regulatory Sequences Capable Of Conferring Expression Of A Heterologous Dna Sequence In Endothelial Cells In Vivo And Uses Thereof
  • Febp1 Protein Vector Host Cells And Method For Making Febp1 Protein
  • Method Of Treating Androgen-Dependent Disorders
  • Methods For Encapsulating Nucleic Acids In Lipid Bilayers
  • Synthetic Transfection Vectors
  • Tumor Targeted Vector
  • Anti-P53 Single-Chain Antibody Fragments And Their Uses
  • Therapy For Cellular Accumulation In Chronic Inflammatory Diseases
  • Hkis Compositions And Methods Of Use
  • Particle Delivery Techniques
  • Method Of Inhibiting Cell Proliferation Using An Anti-Oncogene Protein
  • Transfer Of Molecules Into The Cytosol Of Cells
  • Methods And Reagents For Facilitating Transcription
  • Combination Therapy Using Nucleic Acids And Conventional Drugs
  • Methods And Formulations For Mediating Adeno-Associated Virus (Aav) Attachment And Infection And Methods For Purifying Aav
  • Cationic Lipopolymer As Biocompatible Gene Delivery Agent
  • Febp1 Protein: Vector, Host Cells And Method For Making Febp1 Protein
  • Pca3 Genes
  • Production And Use Of Rat Spermatogonial Stem Cell Lines
  • Use Of Scatter Factor To Enhance Angiogenesis
  • Ecr673: A 7-Transmembrane G-Protein Coupled Receptor
  • Targeted Vectors For Cancer Immunotherapy
  • Nucleic Acid-Lipopolymer Compositions
  • Modified Polynucleotides For Treating Protein Deficiency
  • Mammalian Two-Hybrid System For Screening For Modulators Of The Accumulation Of Metabolic Products
  • Compositions And Methods For Regulated Protein Expression In Gut
  • Host Cells Comprising Cdna Corresponding To The Antigenome Of Nonsegmented Negative Strand Rna Viruses, Further Encoding Antigenically Active Proteins
  • Methods And Compositions For Genomic Modification
  • Method To Improve Translation Of Polypeptides By Using Untranslated Regions From Heat-Shock Proteins
  • Binding Proteins That Bind To Human Fgfr1c, Human Β-Klotho And Both Human Fgfr1c And Human Β-Klotho
  • Genes Displaying Enhanced Expression During Cellular Senescence And Terminal Cell Differentiation And Uses Thereof
  • Vaccine For House Dust Mite Allergen Using Naked Dna
  • Rna Interference Mediating Small Rna Molecules
  • Ultrasonic Catheter Power Control
  • Antisense Modulation Of Ptp1b Expression
  • Antisense Modulation Of Ptp1b Expression
  • Refolding Transforming Growth Factor Beta Family Proteins
  • Method Of Delivery Of Nucleic Acids To A Developing Embryo
  • Construction Of Fully-Deleted Adenovirus-Based Gene Delivery Vectors And Uses Thereof
  • Modified Factor Viii
  • Methods Of Cancer Diagnosis And Therapy Targeted Against A Cancer Stem Line
  • Polypeptide
  • Lead Electrode Incorporating Extracellular Matrix
  • Ultrasound Catheter
  • Anti-Il-17 Receptor A Neutralizing Antibodies
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Modified Polynucleotides Encoding Apoptosis Inducing Factor 1
  • Prevention And Treatment Of Amyloidogenic Disease
  • Lentiviral Triplex Dna, And Vectors And Recombinant Cells Containing Lentiviral Triplex Dna
  • Adamts13 Genes And Proteins And Variants, And Therapeutic Compositions And Methods Of Utilizing The Same
  • Fgf 21 Polypeptides Comprising Two Or More Mutations And Uses Thereof
  • Hutc As Therapy For Alzheimer's Disease
  • High Potency Recombinant Antibodies And Method For Producing Them
  • Treatment Of Peripheral Vascular Disease Using Umbilical Cord Tissue-Derived Cells
  • Manf2 For Treatment Of Parkinson's Disease
  • Mammalian Two-Hybrid System For Screening For Modulators Of The Accumulation Of Metabolic Products
  • Uses Of Fgf21 Polypeptides Comprising Two Or More Mutations
  • Rna Interference Mediating Small Rna Molecules
  • Duplexed Parvovirus Vectors
  • Methods For Therapy Of Neurodegenerative Disease Of The Brain
  • Characterization Of Gene Function Using Double Stranded Rna Inhibition
  • Use Of Marrow-Derived Glial Progenitor Cells As Gene Delivery Vehicles Into The Central Nervous System
  • Targeting Molecule Linked To An Imaging Agent
  • Method Of Treating Bone Disorders Using Tsg-6
  • Gene Expression By Positive Feedback Activation Of A Cell Type-Specific Promoter
  • Human Methionine Synthase Reductase: Cloning, And Methods For Evaluating Risk Of, Preventing, Or Treating Neural Tube Defects, Cardiovascular Disease, Cancer, And Down's Syndrome
  • Efficient And Stable In Vivo Gene Transfer To Cardiomyocytes Using Recombinant Adeno-Associated Virus Vectors
  • Vaccines For Chlamydia Psittaci Infections
  • Antigen Modified Cancer Cell Vaccines For Cancer Therapy
  • Methods For Enhanced Virus-Mediated Dna Transfer Using Molecules With Virus- And Cell-Binding Domains
  • Repair And Regeneration Of Ocular Tissue Using Postpartum-Derived Cells
  • Treatment Of Neurological Injury By Administration Of Human Umbilical Cord Tissue-Derived Cells
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Methods Of Isolating Bipotent Hepatic Progenitor Cells
  • Treatment Of Amyloidogenic Diseases
  • Artificial Chromosomes, Uses Thereof And Methods For Preparing Artificial Chromosomes
  • Charge-Dynamic Polymers And Delivery Of Anionic Compounds
  • Preventing Airway Mucus Production By Administration Of Egf-R Antagonists
  • Plasmid Encoding Feline Bmp-7
  • Methods And Compositions For Genomic Modification
  • Means And Methods For The Specific Modulation Of Target Genes In The Cns And The Eye And Methods For Their Identification
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Recombinant Viruses And Their Use For Treatment Of Atherosclerosis And Other Forms Of Coronary Artery Disease And Method, Reagent, And Kit For Evaluating Susceptibility To Same
  • Delivery Of Therapeutic Gene Products By Intestinal Cell Expression
  • E6 Targeted Protein (E6tp1)
  • Modified Factor Viii
  • Pathotropic Targeted Gene Delivery System For Cancer And Other Disorders
  • Treatment Of Neoplasms With Rna Viruses
  • Self-Containing Lactococcus Strain
  • Polynucleotides Encoding Il-17 Receptor A Antigen Binding Proteins
  • Compositions And Methods For Regulating Angiogenesis
  • Cell Culture Methods For Producing Recombinant Proteins In The Presence Of Reduced Levels Of One Or More Contaminants
  • Methods For Preventing Formation Of Inhibitory Antibodies In The Setting Of Gene Therapy
  • Ligand Targeted Nanocapsules For The Delivery Of Rnai And Other Agents
  • Modified Vaccinia Virus Strains For Use In Diagnostic And Therapeutic Methods
  • Humanized Antibodies That Recognize Beta Amyloid Peptide
  • Distinguishing Pca3 Messenger Rna Species In Benign And Malignant Prostate Tissues
  • Method For Making Multispecific Antibodies Having Heteromultimeric And Common Components
  • Ehrlichia Canis Genes And Vaccines
  • Structural Protein Of Adeno-Associated Virus With Modified Antigenicity, Its Production And Its Use
  • Gene Delivery Vectors Provided With A Tissue Tropism For Smooth Muscle Cells, And/Or Endothelial Cells
  • Nanoparticle-Based Gene Delivery Systems
  • Genetically Engineered Equine Influenza Virus And Uses Thereof
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Serotype Of Adenovirus And Uses Thereof
  • Use Of Vegf And Homologues To Treat Neuron Disorders
  • Antibodies To Fibroblast Growth Factor-Like Polypeptides
  • Vectors Comprising Cpg Islands Without Position Effect Varigation And Having Increased Expression
  • Trp8, A Transient Receptor Potential Channel Expressed In Taste Receptor Cells
  • Mrna Ratios In Urinary Sediments And/Or Urine As A Prognostic And/Or Theranostic Marker For Prostate Cancer
  • Agent For Inducing Apoptosis Comprising Msx1 Or A Gene Encoding The Same As An Active Ingredient
  • Polynucleotide Constructs, Pharmaceutical Compositions And Methods For Targeted Downregulation Of Angiogenesis And Anticancer Therapy
  • Colloidal Metal Compositions And Methods
  • Nucleic Acid Constructs And Cells, And Methods Utilizing Same For Modifying The Electrophysiological Function Of Excitable Tissues
  • High Potency Recombinant Antibodies And Method For Producing Them
  • Methods For Treating Diabetes Using Fibroblast Growth Factor-Like Polypeptides
  • Control Of Gene Expression
  • Calbindin-D28k Protection Against Glucocorticoid Induced Cell Death
  • Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
  • Delivery Of Dna Vaccines Into Fish By Immersion
  • Treatment Of Stroke And Other Acute Neuraldegenerative Disorders Using Postpartum Derived Cells
  • Method And Apparatus For Device Controlled Gene Expression
  • Metabolically Activated Recombinant Viral Vectors And Methods For Their Preparation And Use
  • Telomelysin/Gfp-Expressing Recombinant Virus
  • Adenovirus Vectors Containing Cell Status-Specific Response Elements And Methods Of Use Thereof
  • Compositions And Methods For Therapeutic Use
  • Recombinant Viral And Non-Viral Vectors Containing The Human Urokinase Plasminogen Activator Gene And Its Utilization In The Treatment Of Various Types Of Hepatic, Renal, Pulmonary, Pancreatic And Cardiac Fibrosis And Hypertrophic Scars
  • Methods Of Using Nucleic Acid Vector-Lipid Complexes
  • Method Of Making A Genetically Modified Mammalian Cell
  • Compositions And Methods For Treating Intracellular Diseases
  • Enhanced Mediated Dna Transfer
  • Methods And Compositions For Detection Of Microorganisms And Cells And Treatment Of Diseases And Disorders
  • Means And Methods For Producing Adenovirus Vectors
  • Cell Populations, Methods Of Transdifferentiation And Methods Of Use Thereof
  • Pharmaceutical Compositions With Resistance To Soluble Cea
  • Adenoviral Vector Encoding Human Atonal Homolog-1 (Hath1)
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Methods And Compositions For The Inhibition Of Trpv4
  • Chimeric Newcastle Disease Viruses And Uses Thereof
  • Treating Neurological Disorders
  • Ultrasonic Catheter Power Control
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Methods Of Treating Retinitis Pigmentosa Using Nucleic Acids Encoding Rdcvf1 Or Rdcvf2
  • Production And Use Of Rat Spermatogonial Stem Cell Lines
  • In Vitro Expansion Of Postpartum-Derived Cells In Roller Bottles
  • Conformationally Constrained Parathyroid Hormone (Pth) Analogs
  • P53 Vaccines For The Treatment Of Cancers
  • Biodegradable Immunomodulatory Formulations And Methods For Use Thereof
  • Delivery Of Dna Vaccines Into Fish By Immersion
  • Nanoparticle-Based Gene Delivery Systems
  • Telomelysin/Gfp-Expressing Recombinant Virus
  • Adenovirus Vectors Containing Cell Status-Specific Response Elements And Methods Of Use Thereof
  • High Potency Recombinant Antibodies And Method For Producing Them
  • Methods For Treating Diabetes Using Fibroblast Growth Factor-Like Polypeptides
  • High Molecular Weight, Low Methoxyl Pectins, And Their Production And Uses
  • Nucleic Acid Constructs And Cells, And Methods Utilizing Same For Modifying The Electrophysiological Function Of Excitable Tissues
  • Agent For Inducing Apoptosis Comprising Msx1 Or A Gene Encoding The Same As An Active Ingredient
  • Method And Medicament For Inhibiting The Expression Of A Given Gene
  • Variants Of Pigment Epithelium Derived Factor And Uses Thereof
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Compositions And Methods For Therapeutic Use
  • Use Of Vegf And Homologues To Treat Neuron Disorders
  • Antibodies To Fibroblast Growth Factor-Like Polypeptides
  • Metabolically Activated Recombinant Viral Vectors And Methods For Their Preparation And Use
  • Recombinant Viral And Non-Viral Vectors Containing The Human Urokinase Plasminogen Activator Gene And Its Utilization In The Treatment Of Various Types Of Hepatic, Renal, Pulmonary, Pancreatic And Cardiac Fibrosis And Hypertrophic Scars
  • Serotype Of Adenovirus And Uses Thereof
  • Treatment Of Stroke And Other Acute Neuraldegenerative Disorders Using Postpartum Derived Cells
  • Structural Protein Of Adeno-Associated Virus With Modified Antigenicity, Its Production And Its Use
  • Gene Delivery Vectors Provided With A Tissue Tropism For Smooth Muscle Cells, And/Or Endothelial Cells
  • Polynucleotides Encoding Il-17 Receptor A Antigen Binding Proteins
  • Trp8, A Transient Receptor Potential Channel Expressed In Taste Receptor Cells
  • Mrna Ratios In Urinary Sediments And/Or Urine As A Prognostic And/Or Theranostic Marker For Prostate Cancer
  • Polynucleotide Constructs, Pharmaceutical Compositions And Methods For Targeted Downregulation Of Angiogenesis And Anticancer Therapy
  • Colloidal Metal Compositions And Methods
  • Treatment Of Neoplasms With Rna Viruses
  • Self-Containing Lactococcus Strain
  • Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
  • Means And Methods For Producing Adenovirus Vectors
  • Calbindin-D28k Protection Against Glucocorticoid Induced Cell Death
  • Method And Apparatus For Device Controlled Gene Expression
  • Methods Of Using Nucleic Acid Vector-Lipid Complexes
  • Method Of Making A Genetically Modified Mammalian Cell
  • Chimeric Adenoviruses
  • Control Of Gene Expression
  • Enhanced Mediated Dna Transfer
  • Methods Of Suppressing Hepatitis Virus Infection Using Immunomodulatory Polynucleotide Sequences
  • Method For Making Multispecific Antibodies Having Heteromultimeric And Common Components
  • Ehrlichia Canis Genes And Vaccines
  • Compositions And Methods For Regulating Angiogenesis
  • Cell Culture Methods For Producing Recombinant Proteins In The Presence Of Reduced Levels Of One Or More Contaminants
  • Methods For Preventing Formation Of Inhibitory Antibodies In The Setting Of Gene Therapy
  • Ligand Targeted Nanocapsules For The Delivery Of Rnai And Other Agents
  • Modified Vaccinia Virus Strains For Use In Diagnostic And Therapeutic Methods
  • Vectors Comprising Cpg Islands Without Position Effect Varigation And Having Increased Expression
  • Genetically Engineered Equine Influenza Virus And Uses Thereof
  • Polynucleotides Encoding Il-17 Receptor A Antigen Binding Proteins
  • Genetic Suppression And Replacement
  • Polynucleotides Encoding Antigenic Hiv Type C Polypeptides, Polypeptides And Uses Thereof
  • Conformationally Constrained Parathyroid Hormone (Pth) Analogs
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Defective Sindbis Viral Vector Comprising An Anti-Tumor Gene
  • Variants Of Pigment Epithelium Derived Factor And Uses Thereof
  • Ace2 Activation For Treatment Of Heart, Lung And Kidney Disease And Hypertension
  • Apoptosis Gene Ei24, Compositions, And Methods Of Use
  • Lipoxygenase Proteins And Polynucleotides Encoding The Same
  • Replication Deficient Adenoviral Tnf Vector
  • Mutated Steroid Hormone Receptors, Methods For Their Use And Molecular Switch For Gene Therapy
  • Immunostimulatory Polynucleotide/Immunomodulatory Molecule Conjugates
  • Adeno-Associated Virus Materials And Methods
  • Lipoxygenase Proteins And Polynucleotides Encoding The Same
  • Gene Shinc-2 And Diagnostic And Therapeutic Uses Thereof
  • Methods Of Ameliorating Symptoms Of Herpes Infection Using Immunomodulatory Polynucleotide Sequences
  • Virus Vectors And Methods Of Making And Administering The Same
  • Ip3-Binding Polypeptides And Methods Of Using Them
  • Method For Using Thymosin Β-10 For Gene Therapy Of Solid Malignant Tumors
  • Alphavirus Replicon Vector Systems
  • Ob Fusion Protein Compositions And Methods
  • Calpain Inhibitors And Their Applications
  • Targeted Retrograde Gene Delivery For Neuronal Protection
  • Cmv Vaccines
  • Delivery Of Polynucleotides By Secretory Gland Expression
  • Mammalian Iap Gene Family, Primers, Probes And Detection Methods
  • Self-Deleting Vectors
  • Branched Dendrimeric Structures
  • Genes Displaying Enhanced Expression During Cellular Senescence And Terminal Cell Differentiation And Uses Thereof
  • Use Of Vegf-C To Prevent Restenosis
  • Serotype Of Adenovirus And Uses Thereof
  • Methods Of Treating Neoplasia With Combination Of Target-Cell Specific Adenovirus, Chemotherapy And Radiation
  • Multimeric Forms Of Members Of The Steroid/Thyroid Superfamily Of Receptors With The Ultraspiracle Receptor
  • Extraneous Dna Sequence That Facilitates Hantavirus Gene Expression
  • High Bone Mass Gene Of 11q13.3
  • Remedies For Hepatitis
  • Medicament Comprising Hgf Gene
  • High Bone Mass Gene Of 11q13.3
  • Polynucleotides Encoding Antigenic Hiv Type B Polypeptides, Polypeptides And Uses Thereof
  • High-Affinity Choline Transporter
  • Functional Dna Clone For Hepatitis C Virus (Hcv) And Uses Thereof
  • Modulating Transcription Of Genes In Vascular Cells
  • Nucleic Acids, Vectors And Transformed Cells For Making And Using High Affinity Ip-3 Binding Polypeptides
  • Mutant Loxp Site And Applications Thereof
  • P53 As A Regulator Of Cell Differentiation
  • Use Of Adenoviral E4 Reading Frames To Improve Expression Of A Gene Of Interest
  • Internal Ribosome Entry Site And Vector Containing Same
  • Vectors And Methods For Immunization Or Therapeutic Protocols
  • Methods For Enhancing Survival Of A Neuron
  • Compounds And Methods For Therapy And Diagnosis Of Lung Cancer
  • Surface Receptor Antigen Vaccines
  • Ags Proteins And Nucleic Acid Molecules And Uses Therefor
  • Compositions For Receptor/Liposome Mediated Transfection And Methods Of Using Same
  • Apoptosis Gene Ei24, Compositions, And Methods Of Use
  • Lipoxygenase Proteins And Polynucleotides Encoding The Same
  • Replication Deficient Adenoviral Tnf Vector
  • Human Aggrecanase And Nucleic Acid Compositions Encoding The Same
  • Herpes Simplex Virus Amplicon Vector Targeting System And Method Of Using Same
  • Methods For Regulating The Specific Lineages Of Cells Produced In A Human Hematopoietic Cell Culture, Methods For Assaying The Effect Of Substances On Lineage-Specific Cell Production, And Cell Compositions Produced By These Cultures
  • Mutated Steroid Hormone Receptors, Methods For Their Use And Molecular Switch For Gene Therapy
  • Immunostimulatory Polynucleotide/Immunomodulatory Molecule Conjugates
  • Delivery Of Polynucleotides By Secretory Gland Expression
  • Mammalian Iap Gene Family, Primers, Probes And Detection Methods
  • Self-Deleting Vectors
  • Method For Gene Therapy Using Nucleic Acid Loaded Polymeric Microparticles
  • Methods For Restoring Wild-Type P53 Gene Function
  • Reversal Of Cancer Phenotype By Inhibiting Expression Of Prostate Tumor Inducing Gene
  • Preventing Airway Mucus Production By Administration Of Egf-R Antagonists
  • Retroviral Gene Transfer Vectors
  • Porcine Adenovirus Type 3 Genome
  • Nucleotide Sequences, Proteins, Drugs And Diagnostic Agents Of Use In Treating Cancer
  • Liposome Fusion And Delivery Vehicle
  • Polymeric Complexes For The Transfection Of Nucleic Acids, With Residues Causing The Destabilisation Of Cell Membranes
  • Method And Model For Hair Pigmentation
  • Nucleic Acids, Vectors And Transformed Cells For Making And Using High Affinity Ip-3 Binding Polypeptides
  • Mutant Loxp Site And Applications Thereof
  • P53 As A Regulator Of Cell Differentiation
  • Use Of Adenoviral E4 Reading Frames To Improve Expression Of A Gene Of Interest
  • Branched Dendrimeric Structures
  • Uteroglobin Gene Therapy For Epithelial Cell Cancer
  • Vectors And Methods For Immunization Or Therapeutic Protocols
  • Adenovirus E4 Proteins For Inducing Cell Death
  • Internal Ribosome Entry Site And Vector Containing Same
  • High Bone Mass Gene Of 11q13.3
  • Methods For Enhancing Survival Of A Neuron
  • Compounds And Methods For Therapy And Diagnosis Of Lung Cancer
  • Surface Receptor Antigen Vaccines
  • Ags Proteins And Nucleic Acid Molecules And Uses Therefor
  • Method Of Intracellular Binding Of Target Molecules
  • Stabilized Transient Gene Expression
  • Inhibition Of Smooth Muscle Cell Migration By Heme Oxygenase I
  • Recombinant Animal Viral Nucleic Acids
  • Liver Regeneration Using Pancreas Cells
  • P16 Expression Constructs And Their Application In Cancer Therapy
  • Methods Of Treating Parkinson's Disease Using Recombinant Adeno-Associated Vector (Raav)
  • Medicament Comprising Hgf Gene
  • Hsv Strain Lacking Functional Icp27 And Icp34.5 Genes
  • Compositions For Targeted Gene Delivery
  • Rna Interference Mediating Small Rna Molecules
  • Functional Dna Clone For Hepatitis C Virus (Hcv) And Uses Thereof
  • Targeted Chromosomal Genomic Alterations With Modified Single Stranded Oligonucleotides
  • Imaging, Diagnosis And Treatment Of Disease
  • Modulating Transcription Of Genes In Vascular Cells
  • Gene Delivery Vehicle Expressing The Aptosis-Inducing Proteins Vp2 And/Or Apoptin
  • Structural Protein Of Adeno-Associated Virus With Modified Antigenicity, Its Production And Its Use
  • Method For Detecting Loss Of Wild-Type P53
  • Remedies For Hepatitis
  • Extraneous Dna Sequence That Facilitates Hantavirus Gene Expression
  • Hybrid Amyloid-Beta Antibodies
  • Nucleic Acids Encoding Sb10 Variants
  • Dock-And-Lock (Dnl) Constructs For Human Immunodeficiency Virus (Hiv) Therapy
  • Double-Stranded Oligonucleotides
  • Antisense Modulation Of Ptp1b Expression
  • Replication-Competent Anti-Cancer Vectors
  • Pca3, Pca3 Genes, And Methods Of Use
  • Methods For Genetic Modification Of Hematopoietic Progenitor Cells And Uses Of The Modified Cells
  • Methods Related To Immunostimulatory Nucleic Acid-Induced Interferon
  • Treatment Of Stroke And Other Acute Neural Degenerative Disorders Via Intranasal Administration Of Umbilical Cord-Derived Cells
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Fgf21 Mutants And Uses Thereof
  • Artificial Chromosomes, Uses Thereof And Methods For Preparing Artificial Chromosomes
  • Dopaminergic Neurons Differentiated From Embryonic Cells For Treating Neurodegenerative Diseases
  • Vector
  • Therapeutic Dna Vaccination
  • Mink-Related Genes, Formation Of Potassium Channels And Association With Cardiac Arrhythmia
  • Inhibiting Apoptosis With Adenovirus Rid Protein
  • Generating Replicating Molecules In Vivo
  • Cell Permeable Peptides For Inhibition Of Inflammatory Reactions And Methods Of Use
  • Gene Transfer Into Airway Epithelial Stem Cell By Using Lentiviral Vector Pseudotyped With Rna Virus Or Dna Virus Spike Protein
  • Compositions And Methods For The Induction And Tuning Of Gene Expression
  • G-Protein Coupled Receptors
  • Modified Polynucleotides Encoding Copper Metabolism (Murr1) Domain Containing 1
  • Il-17 Receptor A Antigen Binding Proteins
  • Rna Sequence-Specific Mediators Of Rna Interference
  • Methods Of Cancer Diagnosis And Therapy Targeted Against A Cancer Stem Line
  • Decellularized Bone Marrow Extracellular Matrix
  • Dock-And-Lock (Dnl) Constructs For Human Immunodeficiency Virus (Hiv) Therapy
  • Human Umbilical Cord Tissue Cells For Inhibiting Adverse Immune Response In Histocompatibility-Mismatched Transplantation
  • Modified Polynucleotides Encoding Basic Helix-Loop-Helix Family Member E41
  • Materials And Methods For Reducing Inflammation By Inhibition Of The Atrial Natriuretic Peptide Receptor
  • Antibodies That Bind To Repulsive Guidance Molecule A (Rgma)
  • Colloidal Metal Compositions And Methods
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Expression Of Hiv Polypeptides And Production Of Virus-Like Particles
  • Biodegradable Immunomodulatory Formulations And Methods For Use Thereof
  • Influenza Virus Replication For Vaccine Development
  • Intravascular Delivery Of Nucleic Acid
  • Methods Of Cancer Diagnosis And Therapy Targeted Against A Cancer Stem Line
  • Distinguishing Pca3 Messenger Rna Species In Benign And Malignant Prostate Tissues
  • Promoters Exhibiting Endothelial Cell Specificity And Methods Of Using Same For Regulation Of Angiogenesis
  • Postpartum Cells Derived From Umbilical Cord Tissue, And Methods Of Making And Using The Same
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Vector Encoding An Antibody That Binds 5t4 Antigen
  • Modified Polynucleotides For The Production Of Proteins
  • Cancer Treatment With Endothelin Receptor Antagonists
  • Vectors And Methods To Treat Ischemia
  • Modified Adenovirus Containing A Fiber Replacement Protein
  • Methods And Compositions For Using Sax2
  • Gene Overexpressed In Cancer
  • Use Of Stem Cells To Generate Inner Ear Cells
  • Gene Overexpressed In Cancer
  • Attenuated Negative Strand Viruses With Altered Interferon Antagonist Activity For Use As Vaccines And Pharmaceuticals
  • Complementing Cell Lines
  • Modified Adenovirus Containing A Fiber Replacement Protein
  • In Vitro Construction Of Sv40 Viruses And Pseudoviruses
  • Recombinant P53 Adenovirus Methods And Compositions
  • Method Of Observing Vasculogenesis In Vitro Using Cultured Allantois
  • Humanized Anti-Ccr2 Antibodies And Methods Of Use Therefor
  • Antibodies Against The Rgm A Protein And Uses Thereof
  • Polypeptide Variants Of Sleeping Beauty Transposase
  • Methods For Modulating Skeletal Remodeling And Patterning By Modulating Shn2 Activity, Shn3 Activity, Or Shn2 And Shn3 Activity In Combination
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Modified Polynucleotides For The Production Of Oncology-Related Proteins And Peptides
  • Methods Of Treating Parkinson's Disease Using Viral Vectors
  • Genetic Adjuvants For Immunotherapy
  • Screening Method For Compounds That Promote Differentiation Of Inner Ear Progenitor Cells
  • Vaccinia Virus For Diagnosis And Therapy Of Tumors
  • Means And Methods For Nucleic Acid Delivery Vehicle Design And Nucleic Acid Transfer
  • Rna Sequence-Specific Mediators Of Rna Interference
  • Methods And Compositions For Treating Inflammatory Conditions
  • Rsv-Specific Binding Molecules And Means For Producing Them
  • Fibroblast Growth Factor-Like Polypeptides
  • In Vitro Micro-Organs, And Uses Related Thereto
  • Nucleotide And Protein Sequences Of Nogo Genes And Methods Based Thereon
  • Conformationally Constrained Parathyroid Hormones With Alpha-Helix Stabilizers
  • Methods For Proliferating Cardiomyocytes And Recombinant Vectors Therefor
  • Microorganisms For Therapy
  • Postpartum Cells Derived From Umbilical Tissue And Methods Of Making And Using The Same
  • Gene Delivery System And Methods Of Use
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Screening Methods Using G-Protein Coupled Receptors And Related Compositions
  • Modified Polynucleotides For The Production Of G-Csf
  • Method For Making Multispecific Antibodies Having Heteromultimeric And Common Components
  • Method To Detect Prostate Cancer In A Sample
  • Neublastin Variants
  • Ultrasound Catheter For Providing A Therapeutic Effect To A Vessel Of A Body
  • Bovine Adeno-Associated Viral (Baav) Vector And Uses Thereof
  • Methods And Means For Obtaining Modified Phenotypes
  • Methods And Compositions For Treatment Of Interferon-Resistant Tumors
  • Methods Of Treating Retinal Nerve Fiber Layer Degeneration With Monoclonal Antibodies Against A Retinal Guidance Molecule (Rgm) Protein
  • Murine Monoclonal Anti-Idiotype Antibody 11d10 And Methods Of Use Thereof
  • Expression Of Fusion Proteins
  • Expression Of Fusion Proteins
  • Adeno-Associated Vector Compositions For Expression Of Factor Viii
  • Rna Interference Mediating Small Rna Molecules
  • Method For Treating Cancer, Visualizing Cell Structures, And Isolating Organelles Using Organelle Crystallizing Agents
  • Mast Cell Rasgrp4 Compositions And Related Methods
  • Complementing Cell Lines
  • Materials And Methods For Prevention And Treatment Of Rna Viral Diseases
  • Oxidized Lipids And Uses Thereof In The Treatment Of Inflammatory Diseases And Disorders
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Stable Formulations Of Purified Proteins
  • Terminally Modified Rna
  • Combination Pdgf, Kgf, Igf, And Igfbp For Wound Healing
  • Molecular Characterization Of Chromosome Translocation T(11;18)(Q21;Q21) And Its Correlation To Carcinogenesis
  • Inhibitors Of Cell-Cycle Progression And Uses Related Thereto
  • Aav Scleroprotein, Production And Use Thereof
  • Non-Invasive Gene Targeting To Ocular Cells
  • Human Plasma Hyaluronidase
  • Peptide Vector
  • Compositions And Methods For Sirna Inhibition Of Angiogenesis
  • Osteoactivin Protein And Nucleic Acids Encoding The Same, Compositions And Methods Of Stimulating Bone Differentiation
  • Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter
  • High Potency Sirnas For Reducing The Expression Of Target Genes
  • Genetic Adjuvants For Immunotherapy
  • Compositions, Kits, And Methods Relating To The Human Fez1 Gene, A Novel Tumor Suppressor Gene
  • Glutamic Acid Decarboxylase (Gad) Based Delivery System
  • Methods And Compositions For Modulating Pd1
  • Methods For The Modulation Of Neovascularization And/Or The Growth Of Collateral Arteries And/Or Other Arteries From Preexisting Arteriolar Connections
  • Ob Fusion Protein Compositions And Methods
  • Suppressor Of Ap-1
  • Adenovirus Vectors Containing Cell Status-Specific Response Elements And Methods Of Use Thereof
  • Targeted Gene Modification By Parvoviral Vectors
  • Polynucleotides Encoding Antigenic Hiv Type C Polypeptides, Polypeptides And Uses Thereof
  • Compositions And Methods For The Therapy And Diagnosis Of Prostate Cancer
  • Trp8, A Transient Receptor Potential Channel Expressed In Taste Receptor Cells
  • Gene Repair Involving In Vivo Excision Of Targeting Dna
  • Fibroblast Growth Factor-Like Polypeptides And Variants Thereof
  • Conformationally Constrained Parthyroid Hormone (Pth) Analogs
  • Methods And Compounds For Controlled Release Of Recombinant Parvovirus Vectors
  • Preventing Airway Mucus Production By Administration Of Egf-R Antagonists
  • Synthetic Genes And Genetic Constructs
  • Selective Induction Of Apoptosis To Treat Ocular Disease By Expression Of Pedf
  • Nucleic Acid Compositions For Stimulating Immune Responses
  • Methods Employing And Compositions Containing Defined Oxidized Phospholipids For Prevention And Treatment Of Atherosclerosis
  • Microorganisms For Therapy
  • Expression Construct For Digesting Aggregating Protein And Method Of Inhibiting The Aggregation Of Aggregating Protein
  • Compositions And Methods For Inhibiting Expression Of A Target Gene
  • Hepatocellular Carcinoma-Related Genes And Polypeptides, And Method For Detecting Hepatocellular Carcinomas
  • Pharmaco-Gene Delivery In Human Breast Cancer Cells
  • Murb
  • Cell Cycle Regulated Repressor And Dna Element
  • Use Of The Cytokine Ip-10 As An Anti-Tumor Agent
  • Polynucleotides Encoding My1 Receptor
  • Transcriptional Activators, And Compositions And Uses Related Thereto
  • Defective Platelet Activation In Gαq Deficient Mice
  • Entomopoxvirus-Vertebrate Gene Delivery Vector And Method
  • Interleukin-12 As An Adjuvant For Paramyxoviridae Vaccines
  • Cell Compositions For Use In Transplantation
  • Pharmaco-Gene Delivery In Human Breast Cancer Cells
  • Gene Delivery System
  • Transgene Expression System For Increased Persistence
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Modified Polynucleotides For The Production Of Cosmetic Proteins And Peptides
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Recombinant Adenovirus For Tissue Specific Expression In Heart
  • Methods Of Stimulating Phagocytosis
  • Use Of Hyaluronan In Gene Therapy
  • Methods For Enhanced Retroviral-Mediated Gene Transfer
  • Hyperthermic Inducible Expression Vectors For Gene Therapy And Methods Of Use Thereof
  • Recombinant Adeno-Associated Virus Virions For The Treatment Of Lysosomal Disorders
  • Methods Of Treating Schizophrenia
  • Tissue Electroperforation For Enhanced Drug Delivery
  • Adeno-Associated Virus Capable Of Expressing Factor Ix Protein And Cells Comprising The Same
  • Induction Of Immune Response To Antigens Expressed By Recombinant Adeno-Associated Virus
  • High Efficiency Retroviral Vector Which Contains Genetically Engineered Cellular Non-Coding Sequence Harboring Splicing Acceptor
  • Methods For Introducing Genes Into Mammalian Subjects
  • Methods For Producing And Using In Vivo Pseudotyped Retroviruses Using Envelope Glycoproteins From Lymphocytic Choriomeningitis Virus (Lcmv)
  • Polynucleotide
  • Isolated Stromal Cells And Methods Of Using The Same
  • Target Cell-Specific Adenoviral Vectors Containing E3 And Methods Of Use Thereof
  • Gene Delivery System And Methods Of Use
  • Compositions And Methods For Non-Targeted Activation Of Endogenous Genes
  • Poliovirus Replicons Encoding Therapeutic Agents And Uses Thereof
  • Compositions And Methods For Modulating Vascularization
  • Inhibition Of Hiv-1 Replication By Antisense Rna Expression
  • Bioconjugates And Delivery Of Bioactive Agents
  • Polymerase Iii-Based Expression Of Therapeutic Rnas
  • Control Of Gene Expression In Eukaryotic Cells
  • Methods For Delivering Nucleic Acid Molecules Into Cells And Assessment Thereof
  • Treatment Of Immune Diseases
  • Nucleic Acid Sequence For Potentiating The Expression Of Useful Gene And Method Therefor
  • Stimulation Of Cellular Regeneration And Differentiation In The Inner Ear
  • Manganese Superoxide Dismutase Exon 3-Deleted Isoforms And Nucleic Acid Molecules Encoding The Isoforms
  • Enhanced Homologous Recombination Mediated By Lambda Recombination Proteins
  • Altered Recombinases For Genome Modification
  • Genetic Suppression And Replacement
  • Gene Transfer In Human Lymphocytes Using Retroviral Scfv Cell Targeting
  • Method Of Reducing Neuronal Electrical Activity With A Potassium Channel Subunit
  • Retroviral Vectors
  • Methods For Enhancing Graft Survival By Modulating Heme Oxygenase Activity
  • Methods For Transfecting T Cells
  • Use Of Pro-Apoptotic Factors In Treatment Of Atherosclerosis
  • Methods For Delivering Nucleic Acid Molecules Into Cells And Assessment Thereof
  • Methods For The Treatment Of Hepatic Disorders
  • Methods Of Administering/Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment
  • Antisense Compounds Which Prevent Cell Death And Uses Thereof
  • Methods Of Administering/Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment
  • Toso
  • Lipoproteins As Nucleic Acid Vectors
  • Methods And Compositions For Genomic Modification
  • Methods And Compositions To Induce Antitumor Response
  • In Vivo Stimulation Of Angiogenic Activity
  • Defective Recombinant Adenoviruses Expressing Cytokines For Antitumor Treatment
  • Alphavirus Cdna Vectors
  • Gene Delivery System And Methods Of Use
  • Use Of A Polypeptide As Cell Receptor For Adenoviruses
  • Epithelial Cell Targeting Agent
  • Adenoviral Vector Encoding Anti-Apoptotic Bcl-2 Gene And Uses Thereof
  • Methods For Administration Of Recombinant Gene Delivery Vehicles For Treatment Of Hemophilia And Other Disorders
  • Methods And Compositions For Therapies Using Genes Encoding Secreted Proteins Such As Interferon-Beta
  • Adeno-Associated Vector Compositions For Expression Of Factor Viii
  • Complementing Cell Lines
  • Rna Sequence-Specific Mediators Of Rna Interference
  • Method For Treating Cancer, Visualizing Cell Structures, And Isolating Organelles Using Organelle Crystallizing Agents
  • Rna Interference Mediating Small Rna Molecules
  • Method And Compounds For Controlling Capacitative Calcium Ion Entry Into Mammalian Cells
  • Expression Of Fusion Proteins
  • Expression Of Fusion Proteins
  • Mast Cell Rasgrp4 Compositions And Related Methods
  • Capsid-Modified Recombinant Adenovirus And Methods Of Use
  • Polynucleotides Encoding Stem Cell Growth Factor-Like Polypeptides
  • Adeno-Associated Virus-Delivered Ribozyme Compositions And Methods Of Use
  • Internalisation Of Virus Into Cells
  • Thrombopoietic Compounds
  • Rna Interference Mediating Small Rna Molecules
  • Genetic Adjuvants For Immunotherapy
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Genetic Correction Of Mutated Genes
  • Modified Polynucleotides Encoding Siah E3 Ubiquitin Protein Ligase 1
  • Osteoactivin Protein And Nucleic Acids Encoding The Same, Compositions And Methods Of Stimulating Bone Differentiation
  • Compositions, Kits, And Methods Relating To The Human Fez1 Gene, A Novel Tumor Suppressor Gene
  • Rna Interference Mediating Small Rna Molecules
  • Carcinoma-Related Genes And Polypeptides And Methods Of Use Thereof
  • Rna Interference Mediating Small Rna Molecules
  • Phosphoinositide (4,5) Bisphosphate As A Diagnostic Tool And Target For Cancer Treatment
  • Dimerizing Agents, Their Production And Use
  • Nucleic Acid Sequences And Proteins Involved In Cellular Senescence
  • Modified Factor Viii
  • Nucleotide And Amino Acid Sequences Relating To Respiratory Diseases And Obesity
  • Cell Lines
  • Methods And Compositions For Treating Hypercholesterolemia
  • Compositions And Methods For The Therapy And Diagnosis Of Prostate Cancer
  • Expression Elements
  • Compositions For Blocking The Inhibitory Effect Of Human Crp On Human Leptin
  • Chromosomal Modification Involving The Induction Of Double-Stranded Dna Cleavage And Homologous Recombination At The Cleavage Site
  • Attenuated Influenza Ns1 Variants
  • Immunotherapy Regimes Dependent On Apoe Status
  • Cell Permeable Fusion Protein For Facilitating Reprogramming Induction And Use Thereof
  • Novel Inducible Animal Models Of Stress Behavior
  • Construction Of Fully-Deleted Adenovirus-Based Gene Delivery Vectors And Uses Thereof
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Synthetic Genes And Genetic Constructs
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Cancer Treatment With Endothelin Receptor Antagonists
  • Synthetic Genes And Genetic Constructs Comprising Same I
  • Differentiation Of Mutz-3 Cells To Produce Effective Dendritic Cells
  • Porcine Adenovirus E1 And E4 Regions
  • In Vivo Production Of Proteins
  • Thrombopoietic Compounds
  • Genetic Correction Of Mutated Genes
  • Antibodies To Human Β-Adrenergic Receptor Kinase
  • Rna Interference Mediating Small Rna Molecules
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Modified Polynucleotides Encoding Siah E3 Ubiquitin Protein Ligase 1
  • Anti-Cd98 Antibody Processes
  • Rna Interference Mediating Small Rna Molecules
  • Methods Of Increasing Rdcvf 1 Or Rdcvf 2 Polypeptides In Retinal Cells
  • Modified Polynucleotides Encoding Hepatitis A Virus Cellular Receptor 2
  • Targeted Gene Delivery To Dendritic Cells
  • Rna Interference Mediating Small Rna Molecules
  • Dock-And-Lock (Dnl) Constructs For Human Immunodeficiency Virus (Hiv) Therapy
  • Dlin-Kc2-Dma Lipid Nanoparticle Delivery Of Modified Polynucleotides
  • Humanized Anti-Ccr2 Antibodies And Methods Of Use Therefor
  • Promoterless Cassettes For Expression Of Alpha Virus Structural Proteins
  • Vascular Endothelial Growth Factor 2
  • Methods Of Unidirectional, Site-Specific Integration Into A Genome, Compositions And Kits For Practicing The Same
  • Rna Sequence-Specific Mediators Of Rna Interference
  • Refolding Transforming Growth Factor Beta Family Proteins
  • Cytokines And Neuroantigens For Treatment Of Immune Disorders
  • Control Of Gene Expression
  • Repair And Regeneration Of Renal Tissue Using Human Umbilical Cord Tissue-Derived Cells
  • Gata-6 Transcription Factor: Compositions And Methods
  • Human Cytokine Polypeptide
  • Carcinoma-Related Genes And Polypeptides And Methods Of Use Thereof
  • Replication Deficient Adenovirus Vectors And Methods Of Making And Using Them
  • Pneumococcal Surface Protein C (Pspc), Epitopic Regions And Strain Selection Thereof, And Uses Therefor
  • Antibodies For Apoptosis Ei24 Protein And Methods Of Use
  • Vector System
  • Compositions And Methods For The Induction And Tuning Of Gene Expression
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Methods Of Treating Metabolic Disease
  • Methods And Means For Obtaining Modified Phenotypes
  • Discovery, Localization, Harvest, And Propagation Of An Fgf2 And Bdnf-Responsive Population Of Neural And Neuronal Progenitor Cells In The Adult Human Forebrain
  • Helper-Free, Totally Defective Adenovirus For Gene Therapy
  • Methods And Means For Obtaining Modified Phenotypes
  • Modified Virus Vectors And Methods Of Making And Using The Same
  • Secreted Proteins
  • Humanized Anti-Ccr2 Antibodies And Methods Of Use Therefor
  • Transposon System And Methods Of Use
  • Expression Cassettes Endcoding Hiv-1 South African Subtype C Modified Env Proteins With Deletions In V1 And V2
  • Selectively Replicating Viral Vectors
  • Anionic Charge-Dynamic Polymers For Release Of Cationic Agents
  • Microorganisms For Therapy
  • Methods Useful For Generating Highly Mannosylated Pseudotyped Lentiviral Vector Particles Comprising A Vpx Protein
  • P. Gingivalis Vaccine
  • Peptide Compositions And Their Use Against The Hepatitis C Virus
  • Cryptosporidium Hominis Genes And Gene Products For Chemotherapeutic, Immunoprophylactic And Diagnostic Applications
  • Retinal Dystrophy-Associated Protein And Uses Thereof
  • Nucleic Acids Encoding Modulators Of Body Weight
  • Synthetic Genes And Genetic Constructs
  • Microorganisms For Therapy
  • Modified Hiv Env Polypeptides
  • Method And Medicament For Inhibiting The Expression Of A Given Gene
  • Methods Of Administering Porcine B-Domainless Fviii
  • Rna Interference Mediating Small Rna Molecules
  • Modified Zinc Finger Binding Proteins
  • Modified Polynucleotides For The Production Of Proteins
  • Methods For Treating Tweak-Related Conditions
  • Anionic Charge-Dynamic Polymers For Release Of Cationic Agents
  • Packaging Cells For Producing Retrovirus Pseudotyped With An E2 Alphavirus Glycoprotein
  • Binding Domains Of Proteins Of The Repulsive Guidance Molecule (Rgm) Protein Family And Functional Fragments Thereof, And Their Use
  • Recombinant Retrovirus Pseudotyped With A E2 Alphavirus Glycoprotein
  • Promoters Exhibiting Endothelial Cell Specificity And Methods Of Using Same
  • Method To Detect Prostate Cancer In A Sample
  • Duplexed Parvovirus Vectors
  • Microorganisms For Therapy
  • Polynucleotide Constructs, Pharmaceutical Compositions And Methods For Targeted Downregulations Of Angiogenesis And Anticancer Therapy
  • Distinguishing Pca3 Messenger Rna Species In Benign And Malignant Prostate Tissues
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Rna Sequence-Specific Mediators Of Rna Interference
  • Pca3, Pca3 Genes, And Methods Of Use
  • Method For Producing A Protein Of Interest In A Primate
  • Regeneration And Repair Of Neural Tissue Using Postpartum-Derived Cells
  • Prevention And Treatment Of Amyloidogenic Disease
  • Methods Of Isolating Bipotent Hepatic Progenitor Cells
  • Chemosensitizing With Liposomes Containing Oligonucleotides
  • Materials And Methods For Treating Oncological Disease
  • Bioactive Peptides And Peptide Derivatives Of Parathyroid Hormone (Pth) And Parathyroid Hormone-Related Peptide (Pthrp)
  • Use Of Human Plasma Hyaluronidase In Cancer Treatment
  • Porcine Cells Comprising An Adenovirus E3 Gene Region
  • Trp8, A Transient Receptor Potential Channel Expressed In Taste Receptor Cells
  • Gene Transfer Method
  • Peptides For Gene Delivery
  • Compositions And Methods For Enhancing Oligonucleotide-Mediated Gene Alteration
  • Dna Containing Variant Frt Sequences
  • Compositions And Methods For Activating Genes Of Interest
  • Recombinant Viral Nucleic Acids
  • Method Of In Vitro Preconditioning Healthy Donor's Myoblasts Before Transplantation Thereof In Compatible Patients Suffering Of Myopathies Like Muscular Dystrophy, For Improving Transplantation Success
  • Protein Associated With Cell Stress Response
  • Complementing Cell Lines
  • Organotypic Intestinal Culture And Methods Of Use Thereof
  • Genetic Demonstration Of Requirement For Nkx6.1 And Nkx2.2 In Ventral Neuron Generation
  • Method For Introducing And Expressing Genes In Animal Cells, And Live Invasive Bacterial Vectors For Use In The Same
  • Universal Gm-Csf Expressing Bystander Human K562 Cell Line
  • Method Of Delivering Genes To The Central Nervous System Of A Mammal
  • Methods Of Cancer Diagnosis And Therapy Targeted Against A Cancer Stem Line
  • Polynucleotides Encoding A Super-Active Porcine Growth Hormone Releasing Hormone Analog
  • Antisense Modulation Of Ptp1b Expression
  • Osteopontin-Related Compositions And Methods
  • Telomerase Reverse Transcriptase Fragments And Uses Thereof
  • Nucleic Acid Constructs And Cells, And Methods Utilizing Same For Modifying The Electrophysiological Function Of Excitable Tissues
  • Transgenic Animals And Cell Lines For Screening Drugs Effective For The Treatment Or Prevention Of Alzheimer's Disease
  • Compositions For Receptor/Liposome Mediated Transfection And Methods Of Using Same
  • Methods Of Increasing Lean Tissue Mass Using Ob Protein Compositions
  • Compositions And Methods For Efficient Aav Vector Production
  • Methods For Producing Micrornas
  • Recombiant Lentivirus Comprising An E2 Alphavirus Glycoprotein That Binds To Dc-Sign
  • Delivery Of Multiple Genes To Cells Using Plural Adeno-Associated Viral Vectors
  • Hair Follicle Dna Delivery System
  • Methods And Reagents For Modulating Tgf-Β Superfamily Signaling
  • Osteopontin-Related Compositions And Methods
  • Methods Of Preventing And Treating Respiratory Viral Infection Using Immunomodulatory Polynucleotide Sequences
  • Neural Transplantation Using Pluripotent Neuroepithelial Cells
  • Stable Lipid-Comprising Drug Delivery Complexes And Methods For Their Production
  • Induction Of Mucosal Tolerance To Antigens
  • Rsv-Specific Binding Molecules And Means For Producing Them
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Rsv-Specific Binding Molecule
  • Oligonucleotide Compositions With Enhanced Efficiency
  • Methods And Compositions For Modulating Pd1
  • Method Of Targeting Gene Delivery Using Viral Vectors
  • Methods Of Treating Of Diabetes And Obesity Using Fgf21 Mutants
  • Secreted Proteins
  • Prostate Cancer Prognostic Compositions And Kits
  • Microorganisms Carrying A Tumor Antigen
  • Cell Permeable Fusion Protein For Facilitating Reprogramming Induction And Use Thereof
  • Modulation Of Stem Cells Using Zinc Finger Proteins
  • Biodegradable Cationic Polymers And Uses Thereof
  • Compositions And Methods For Increasing Vascularization
  • Genetically Engineered Swine Influenza Virus And Uses Thereof
  • P450/Acetaminophen Genetically Directed Enzyme Prodrug Therapy (Gdept)
  • Method Of Using An Adenoviral Vector Encoding A Retinoblastoma Protein To Treat Hyperproliferating Cells
  • Polynucleotide
  • In Vivo Selection Of Primitive Hematopoietic Cells
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Methods And Compositions For Inhibition Of Viral Replication
  • Gene Therapy For Neurodegenerative Disorders
  • Use Of Vegf-D Gene To Prevent Restenosis
  • Stem Cell Beacon
  • Rsv Specific Binding Molecule
  • Ace2 Activation For Treatment Of Heart, Lung And Kidney Disease And Hypertension
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Method Of Stimulating An Immune Response Using A Pseudotyped Lentivirus
  • Methods For Treating Inflammatory Bowel Disease
  • Method For The Diagnosis And Prognosis Of Malignant Diseases
  • Soft Tissue Repair And Regeneration Using Postpartum-Derived Cells And Cell Products
  • Modified Polynucleotides Encoding Aquaporin-5
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Methods For Modulating Bone Formation And Mineralization By Modulating Krc Activity
  • Polynucleotides Encoding Antigenic Hiv Type B Polypeptides, Polypeptides, And Uses Thereof
  • Human Β-Adrenergic Receptor Kinase Polypeptide And Methods
  • Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
  • Thrombopoietic Compounds
  • Cdna Corresponding To The Antigenome Of Nonsegmented Negative Stranded Rna Viruses And Process For The Production Of Such Viruses
  • Stable Lipid-Comprising Drug Delivery Complexes And Methods For Their Production
  • Methods And Compositions Comprising Dna Damaging Agents And P53
  • Self-Replicating Episomal Expression Vectors Conferring Tissue-Specific Gene Expression
  • Bioconjugates And Delivery Of Bioactive Agents
  • Prevention And Treatment Of Amyloidogenic Disease
  • Ribozyme Therapy For The Treatment Of Proliferative Skin And Eye Diseases
  • Glutamic Acid Decarboxylase (Gad) Based Delivery System
  • Compositions And Methods For Sensitizing And Inhibiting Growth Of Human Tumor Cells
  • Ags Proteins And Nucleic Acid Molecules And Uses Thereof
  • Methods And Compositions Useful For Stimulating An Immune Response
  • Compositions And Methods For The Therapeutic Use Of An Atonal-Associated Sequence For Deafness, Osteoarthritis, And Abnormal Cell Proliferation
  • Adenovirus Encoding Human Adenylylcyclase (Ac) Vi
  • Adenovirus E1b Shuttle Vectors
  • Cancer Gene Therapy Based On Translational Control Of A Suicide Gene
  • Thymidine Kinase Mutants
  • Hybrid Compositions For Intracellular Targeting
  • Recombinant, Active Caspases And Uses Thereof
  • Methods Of Delivering A Physiologically Active Polypeptide To A Mammal
  • Gene Transfer In Chickens By Introduction Of Dna Into Muscle In Ovo
  • Nucleotide Sequence Encoding The Enzyme I Scei And The Use Thereof
  • Chicken Embryo Lethal Orphan (Celo) Virus Gam-1
  • Integrative Protein-Dna Cochleate Formulations And Methods For Transforming Cells
  • Methods And Compositions For Treating Abnormal Cell Growth Related To Unwanted Guanine Nucleotide Exchange Factor Activity
  • Bovine Adenovirus Type 3 Genome And Vector Systems Derived Therefrom
  • Method For Preserving Infectious Recombinant Viruses, Aqueous Viral Suspension And Use As Medicine
  • Nk-1 Receptor Antagonists For Prevention Of Neurogenic Inflammation In Gene Therapy
  • Replicon Based Activation Of Endogenous Genes
  • Capsid-Modified Recombinant Adenovirus And Methods Of Use
  • Retrotransposon And Methods
  • Genetically Altered Mammalian Embryonic Stem Cells, Their Living Progeny, And Their Therapeutic Application For Improving Cardiac Function After Myocardial Infarction
  • Antisense Modulation Of Ptp1b Expression
  • Combination Viral-Based And Gene-Based Therapy Of Tumors
  • Compositions And Method For Non-Targeted Activation Of Endogenous Genes
  • Intracellular Inhibitors Of Gq Protein Signaling
  • Molecular Clones With Mutated Hiv Gag/Pol, Siv Gag And Siv Env Genes
  • Thymidine Kinase Mutants
  • Adenovirus Encoding Human Adenylylcyclase (Ac) Vi
  • Adenovirus E1b Shuttle Vectors
  • Cancer Gene Therapy Based On Translational Control Of A Suicide Gene
  • Ribozyme Therapy For The Treatment Of Proliferative Skin And Eye Diseases
  • Prevention And Treatment Of Amyloidogenic Disease
  • Glutamic Acid Decarboxylase (Gad) Based Delivery System
  • Compositions And Methods For Sensitizing And Inhibiting Growth Of Human Tumor Cells
  • Methods And Compositions Comprising Dna Damaging Agents And P53
  • Self-Replicating Episomal Expression Vectors Conferring Tissue-Specific Gene Expression
  • Bioconjugates And Delivery Of Bioactive Agents
  • Lentiviral Ltr-Deleted Vector
  • Compositions And Methods For The Therapeutic Use Of An Atonal-Associated Sequence For Deafness, Osteoarthritis, And Abnormal Cell Proliferation
  • Complementing Cell Lines
  • Ags Proteins And Nucleic Acid Molecules And Uses Thereof
  • Methods And Compositions Useful For Stimulating An Immune Response
  • Adenovirus Vectors Specific For Cells Expressing Androgen Receptor And Methods Of Use Thereof
  • Immunization Of Infants
  • Nucleic Acid Molecules Comprising A Neocentromere
  • Methods Of Modulating The Expression Of Genes Using Ultraspiracle Receptor
  • Recombinant P53 Adenovirus Methods And Compositions
  • Method For Preserving Infectious Recombinant Viruses, Aqueous Viral Suspension And Use As Medicine
  • Recombinant, Active Caspases And Uses Thereof
  • Gene Transfer In Chickens By Introduction Of Dna Into Muscle In Ovo
  • Nucleotide Sequence Encoding The Enzyme I Scei And The Use Thereof
  • Methods Of Preventing And Treating Respiratory Viral Infection Using Immunomodulatory Polynucleotide Sequences
  • Methods For Producing Micrornas
  • Recombiant Lentivirus Comprising An E2 Alphavirus Glycoprotein That Binds To Dc-Sign
  • Methods Of Isolating Bipotent Hepatic Progenitor Cells
  • Chicken Embryo Lethal Orphan (Celo) Virus Gam-1
  • Methods For Producing Soluble, Biologically-Active Disulfide-Bond Containing Eukaryotic Proteins In Bacterial Cells
  • Integrative Protein-Dna Cochleate Formulations And Methods For Transforming Cells
  • Methods And Compositions For Treating Abnormal Cell Growth Related To Unwanted Guanine Nucleotide Exchange Factor Activity
  • Bovine Adenovirus Type 3 Genome And Vector Systems Derived Therefrom
  • Modified Adeno-Associated Virus Vector Capable Of Expression From A Novel Promoter
  • Methods Of Delivering A Physiologically Active Polypeptide To A Mammal
  • Gene Transfer Method
  • Immunologically Privileged Cells And Uses Thereof
  • Methods And Means For Targeted Gene Delivery
  • Pneumococcal Surface Protein C (Pspc), Epitopic Regions And Strain Selection Thereof, And Uses Therefor
  • Transgenic Animals And Cell Lines For Screening Drugs Effective For The Treatment Or Prevention Of Alzheimer's Disease
  • Hair Follicle Dna Delivery System
  • Methods And Reagents For Modulating Tgf-Β Superfamily Signaling
  • Delivery Of Multiple Genes To Cells Using Plural Adeno-Associated Viral Vectors
  • Stable Lipid-Comprising Drug Delivery Complexes And Methods For Their Production
  • Treatment Of Diseases By Site-Specific Instillation Of Cells Or Site-Specific Transformation Of Cells And Kits Therefor
  • Transgenic Animals And Cell Lines For Screening Drugs Effective For The Treatment Or Prevention Of Alzheimer's Disease
  • Porcine Cells Comprising An Adenovirus E3 Gene Region
  • Trp8, A Transient Receptor Potential Channel Expressed In Taste Receptor Cells
  • Osteopontin-Related Compositions And Methods
  • Telomerase Reverse Transcriptase Fragments And Uses Thereof
  • Nucleic Acid Constructs And Cells, And Methods Utilizing Same For Modifying The Electrophysiological Function Of Excitable Tissues
  • Chemosensitizing With Liposomes Containing Oligonucleotides
  • I-Crei Derived Single-Chain Meganuclease And Uses Thereof
  • Compositions And Methods For Treating Pancreatic Cancer
  • Thrombopoietic Compounds
  • Universal Gm-Csf Expressing Bystander Human K562 Cell Line
  • Genetic Demonstration Of Requirement For Nkx6.1 And Nkx2.2 In Ventral Neuron Generation
  • Method For Introducing And Expressing Genes In Animal Cells, And Live Invasive Bacterial Vectors For Use In The Same
  • Genes Encoding Hormone And Lytic Peptides
  • Antisense Modulation Of Ptp1b Expression
  • Nucleic Acids Encoding Potassium Channel Interactors
  • Methods And Compositions For Using Sax2
  • Promoters Exhibiting Endothelial Cell Specificity And Methods Of Using Same For Regulation Of Angiogenesis
  • Method Of Administering Porcine B-Domainless Fviii
  • Nucleic Acid Compositions For Stimulating Immune Responses
  • Thrombopoietic Compounds
  • Cdna Corresponding To The Antigenome Of Nonsegmented Negative Stranded Rna Viruses And Process For The Production Of Such Viruses
  • Stable Lipid-Comprising Drug Delivery Complexes And Methods For Their Production
  • Surface Receptor Antigen Vaccines
  • Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
  • Genetic Inhibition By Double-Stranded Rna
  • Gene Therapy For Tumors Using Minus-Strand Rna Viral Vectors Encoding Immunostimulatory Cytokines
  • Rapid In Vivo Identification Of Biologically Active Nucleases
  • Split Dose Administration
  • Compositions And Methods For Inhibiting Expression Of A Target Gene
  • Amyloid Peptide Inactivating Enzyme To Treat Alzheimer's Disease Peripherally
  • Treatment Of Tumors With Genetically Engineered Herpes Virus
  • Inhibition Of Stat3 Signal Transduction For Human Cancer Therapy
  • Rsv-Specific Binding Molecules And Means For Producing Them
  • Charge-Dynamic Polymers And Delivery Of Anionic Compounds
  • Treatment Of Stroke And Other Acute Neural Degenerative Disorders Using Postpartum-Derived Cells
  • Recombinant Retrovirus Pseudotyped With E2 Alphavirus Glycoprotein
  • Methods Of Inducing Regulated Pancreatic Hormone Production In Non-Pancreatic Islet Tissues
  • Modified Zinc Finger Binding Proteins
  • Modified Polynucleotides Encoding Aryl Hydrocarbon Receptor Nuclear Translocator
  • Treatment Of Copd, Gastro-Esophageal Reflux Disease (Gerd), Food Allergies And Other Gastrointestinal Conditions And Disorders Ameliorated By Proper Histamine Management Using A Combination Of Histidine Decarboxylase Inhibitors, Lra Drugs, Anti-H1 And/Or Anti-H2 Drugs
  • Methods And Compositions For The Inhibition Of Trpv4
  • Methods And Compositions For Modulating Pd1
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Immuno Gene Therapy For Treatment Of Cancer And Hyperproliferative Diseases
  • Genetically Engineered Swine Influenza Virus And Uses Thereof
  • Compositions Comprising Polynucleotides Encoding Rdcvf1 Or Rdcvf2
  • Treatment Of Amyotrophic Lateral Sclerosis Using Umbilical Derived Cells
  • Lentiviral Vectors Pseudotyped With A Sindbis Virus Envelope Glycoprotein
  • Fgf21 Mutants And Uses Thereof
  • Combination Enzyme Replacement And Small Molecule Therapy For Treatment Of Lysosomal Storage Diseases
  • Materials And Methods For Treatment Of Inflammatory And Cell Proliferation Disorders
  • Targeted Integration And Expression On Exogenous Nucleic Acid Sequences
  • Metabolically Activated Recombinant Viral Vectors And Methods For Their Preparation And Use
  • Lentiviral Triplex Dna, And Vectors And Recombinant Cells Containing Lentiviral Triplex Dna
  • Vectors Carrying Therapeutic Genes Encoding Antimicrobial Peptides For Gene Therapy
  • Osteoactivin Protein And Nucleic Acids Encoding The Same, Compositions And Methods Of Stimulating Bone Differentiation
  • Adenoviral Vectors Encoding Erythropoietin And Their Use In Gene Therapy
  • Delivery Of Nucleic Acid Into Aquatic Animals
  • In Vivo Assay For Intravasation
  • Rna Sequence-Specific Mediators Of Rna Interference
  • Modified Virus Vectors And Methods Of Making And Using The Same
  • Antibody To Secreted Polypeptide
  • Methods For Producing And Using In Vivo Pseudotyped Retroviruses Using Envelope Glycoproteins From Lymphocytic Choriomeningitis Virus (Lcmv)
  • Nucleic Acid-Lipopolymer Compositions
  • Polynucleotides Encoding Rod-Derived Cone Viability Factor (Rdcvf) And Methods Of Using The Same
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Intravascular Delivery Of Non-Viral Nucleic Acid
  • Modified P53 Tetramerization Domains Having Hydrophobic Amino Acid Substitutions
  • Interferon Inducing Genetically Engineered Attenuated Viruses
  • Polynucleotide
  • Use Of Magnesium (Mg2+) For The Preparation Of A Therapeutic Composition For Transfection Of A Polynucleotide Into A Cell And Compositions Useful In Gene Therapy
  • Single Chain Antibody Against Mutant P53
  • Use Of Decorin For Increasing Muscle Mass
  • Anti-Nucleolin Agent-Conjugated Nanoparticles
  • Formulation And Delivery Of Plga Microspheres
  • Complementing Cell Lines
  • Fgf21 Polypeptides Comprising Two Or More Mutations And Uses Thereof
  • Modified Multilayered Film
  • Promoters Exhibiting Endothelial Cell Specificity And Methods Of Using Same For Regulation Of Angiogenesis
  • Humanized Antibodies That Recognize Beta Amyloid Peptide
  • Pin1 As A Marker For Abnormal Cell Growth
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/38410

    DOI

    http://dx.doi.org/10.1038/38410

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1048288589

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9305836


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "author": [
          {
            "familyName": "Verma", 
            "givenName": "Inder M.", 
            "id": "sg:person.0711723174.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711723174.90"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Somia", 
            "givenName": "Nikunj", 
            "id": "sg:person.01242313335.88", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242313335.88"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/978-3-642-75608-5_5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008839676", 
              "https://doi.org/10.1007/978-3-642-75608-5_5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm1095-1017", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013283766", 
              "https://doi.org/10.1038/nm1095-1017"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.93.21.11341", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017709590"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.91.13.6196", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019406962"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.88.4.1330", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022712047"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1146/annurev.ne.19.030196.001405", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035845383"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.94.19.10319", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041371758"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1128/mcb.10.8.4239", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042061197"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/1074-7613(94)90074-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042449328"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.85.9.3150", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042869850"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.89.22.10892", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051834992"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/scientificamerican0697-102", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1056556857", 
              "https://doi.org/10.1038/scientificamerican0697-102"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/scientificamerican1190-68", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1056630472", 
              "https://doi.org/10.1038/scientificamerican1190-68"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.270.5235.404", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062551465"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.270.5235.470", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062551476"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.270.5235.475", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062551477"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.277.5332.1662", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062557965"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/j.1460-2075.1992.tb05376.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1075557737"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1096/fasebj.11.8.9240963", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1083123704"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1997-09", 
        "datePublishedReg": "1997-09-01", 
        "genre": "non_research_article", 
        "id": "sg:pub.10.1038/38410", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0090-0028", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6648", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "389"
          }
        ], 
        "name": "Gene therapy - promises, problems and prospects", 
        "pagination": "239-242", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "e60a5aed5d67e5868181cb161ebf131e1edf4235e0f538910deb5e80658ed6de"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9305836"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0410462"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/38410"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1048288589"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/38410", 
          "https://app.dimensions.ai/details/publication/pub.1048288589"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T12:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000361_0000000361/records_53981_00000001.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://www.nature.com/nature/journal/v389/n6648/full/389239a0.html"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/38410'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/38410'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/38410'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/38410'


     

    This table displays all metadata directly associated to this object as RDF triples.

    123 TRIPLES      19 PREDICATES      45 URIs      20 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/38410 schema:author N4a71d27aff224bcd832d731cc06384d6
    2 schema:citation sg:pub.10.1007/978-3-642-75608-5_5
    3 sg:pub.10.1038/nm1095-1017
    4 sg:pub.10.1038/scientificamerican0697-102
    5 sg:pub.10.1038/scientificamerican1190-68
    6 https://doi.org/10.1002/j.1460-2075.1992.tb05376.x
    7 https://doi.org/10.1016/1074-7613(94)90074-4
    8 https://doi.org/10.1073/pnas.85.9.3150
    9 https://doi.org/10.1073/pnas.88.4.1330
    10 https://doi.org/10.1073/pnas.89.22.10892
    11 https://doi.org/10.1073/pnas.91.13.6196
    12 https://doi.org/10.1073/pnas.93.21.11341
    13 https://doi.org/10.1073/pnas.94.19.10319
    14 https://doi.org/10.1096/fasebj.11.8.9240963
    15 https://doi.org/10.1126/science.270.5235.404
    16 https://doi.org/10.1126/science.270.5235.470
    17 https://doi.org/10.1126/science.270.5235.475
    18 https://doi.org/10.1126/science.277.5332.1662
    19 https://doi.org/10.1128/mcb.10.8.4239
    20 https://doi.org/10.1146/annurev.ne.19.030196.001405
    21 schema:datePublished 1997-09
    22 schema:datePublishedReg 1997-09-01
    23 schema:genre non_research_article
    24 schema:inLanguage en
    25 schema:isAccessibleForFree false
    26 schema:isPartOf N45dde68751584552adff02e6e6fa66e3
    27 N7301ba5ab5644d4a953234a4f7b1e33b
    28 sg:journal.1018957
    29 schema:name Gene therapy - promises, problems and prospects
    30 schema:pagination 239-242
    31 schema:productId N4589a388aec54dc5af5559b57fcdb053
    32 N5aff2fd7468e4ba6ab147690224d79f8
    33 N66b314ffcdc745a88b38cccbf5485d2c
    34 N7944e758833846f7897d1dca7f600d7d
    35 Nb9d7065545d44b26a48efda86f789063
    36 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048288589
    37 https://doi.org/10.1038/38410
    38 schema:sdDatePublished 2019-04-11T12:11
    39 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    40 schema:sdPublisher N6a7553dc3c054b92af5516eedf644268
    41 schema:url http://www.nature.com/nature/journal/v389/n6648/full/389239a0.html
    42 sgo:license sg:explorer/license/
    43 sgo:sdDataset articles
    44 rdf:type schema:ScholarlyArticle
    45 N03822cc35cd14c218e00d15dc2b46b19 rdf:first sg:person.01242313335.88
    46 rdf:rest rdf:nil
    47 N4589a388aec54dc5af5559b57fcdb053 schema:name pubmed_id
    48 schema:value 9305836
    49 rdf:type schema:PropertyValue
    50 N45dde68751584552adff02e6e6fa66e3 schema:volumeNumber 389
    51 rdf:type schema:PublicationVolume
    52 N4a71d27aff224bcd832d731cc06384d6 rdf:first sg:person.0711723174.90
    53 rdf:rest N03822cc35cd14c218e00d15dc2b46b19
    54 N5aff2fd7468e4ba6ab147690224d79f8 schema:name readcube_id
    55 schema:value e60a5aed5d67e5868181cb161ebf131e1edf4235e0f538910deb5e80658ed6de
    56 rdf:type schema:PropertyValue
    57 N66b314ffcdc745a88b38cccbf5485d2c schema:name nlm_unique_id
    58 schema:value 0410462
    59 rdf:type schema:PropertyValue
    60 N6a7553dc3c054b92af5516eedf644268 schema:name Springer Nature - SN SciGraph project
    61 rdf:type schema:Organization
    62 N7301ba5ab5644d4a953234a4f7b1e33b schema:issueNumber 6648
    63 rdf:type schema:PublicationIssue
    64 N7944e758833846f7897d1dca7f600d7d schema:name dimensions_id
    65 schema:value pub.1048288589
    66 rdf:type schema:PropertyValue
    67 Nb9d7065545d44b26a48efda86f789063 schema:name doi
    68 schema:value 10.1038/38410
    69 rdf:type schema:PropertyValue
    70 sg:journal.1018957 schema:issn 0090-0028
    71 1476-4687
    72 schema:name Nature
    73 rdf:type schema:Periodical
    74 sg:person.01242313335.88 schema:familyName Somia
    75 schema:givenName Nikunj
    76 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242313335.88
    77 rdf:type schema:Person
    78 sg:person.0711723174.90 schema:familyName Verma
    79 schema:givenName Inder M.
    80 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711723174.90
    81 rdf:type schema:Person
    82 sg:pub.10.1007/978-3-642-75608-5_5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008839676
    83 https://doi.org/10.1007/978-3-642-75608-5_5
    84 rdf:type schema:CreativeWork
    85 sg:pub.10.1038/nm1095-1017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013283766
    86 https://doi.org/10.1038/nm1095-1017
    87 rdf:type schema:CreativeWork
    88 sg:pub.10.1038/scientificamerican0697-102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056556857
    89 https://doi.org/10.1038/scientificamerican0697-102
    90 rdf:type schema:CreativeWork
    91 sg:pub.10.1038/scientificamerican1190-68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056630472
    92 https://doi.org/10.1038/scientificamerican1190-68
    93 rdf:type schema:CreativeWork
    94 https://doi.org/10.1002/j.1460-2075.1992.tb05376.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1075557737
    95 rdf:type schema:CreativeWork
    96 https://doi.org/10.1016/1074-7613(94)90074-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042449328
    97 rdf:type schema:CreativeWork
    98 https://doi.org/10.1073/pnas.85.9.3150 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042869850
    99 rdf:type schema:CreativeWork
    100 https://doi.org/10.1073/pnas.88.4.1330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022712047
    101 rdf:type schema:CreativeWork
    102 https://doi.org/10.1073/pnas.89.22.10892 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051834992
    103 rdf:type schema:CreativeWork
    104 https://doi.org/10.1073/pnas.91.13.6196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019406962
    105 rdf:type schema:CreativeWork
    106 https://doi.org/10.1073/pnas.93.21.11341 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017709590
    107 rdf:type schema:CreativeWork
    108 https://doi.org/10.1073/pnas.94.19.10319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041371758
    109 rdf:type schema:CreativeWork
    110 https://doi.org/10.1096/fasebj.11.8.9240963 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083123704
    111 rdf:type schema:CreativeWork
    112 https://doi.org/10.1126/science.270.5235.404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062551465
    113 rdf:type schema:CreativeWork
    114 https://doi.org/10.1126/science.270.5235.470 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062551476
    115 rdf:type schema:CreativeWork
    116 https://doi.org/10.1126/science.270.5235.475 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062551477
    117 rdf:type schema:CreativeWork
    118 https://doi.org/10.1126/science.277.5332.1662 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062557965
    119 rdf:type schema:CreativeWork
    120 https://doi.org/10.1128/mcb.10.8.4239 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042061197
    121 rdf:type schema:CreativeWork
    122 https://doi.org/10.1146/annurev.ne.19.030196.001405 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035845383
    123 rdf:type schema:CreativeWork
     




    Preview window. Press ESC to close (or click here)


    ...